exv4w13






Exhibit 4.13




SHARE SUBSCRIPTION AGREEMENT




     SHARE SUBSCRIPTION AGREEMENT (the “Agreement”), dated as of 18 April, 2011, by and among
Semiconductor Manufacturing International Corporation (the “Company”), and Country Hill Limited
(the “Investor”).



WHEREAS




     A. The Investor wishes to subscribe, and the Company wishes to issue, upon the terms
and conditions stated in this Agreement:




	 	(a)	 	an aggregate of 360,589,053 convertible preferred shares, with a
nominal value of US$0.0004 per share, of the Company, the rights of which are set
out in Schedule A to this Agreement (“Convertible Preferred Shares”) at a
subscription price of HK$5.3900 per share; and
	 
	 	(b)	 	72,117,810 warrants for the subscription of 72,117,810 Convertible
Preferred Shares (the “Warrants”), the rights relating to which are contained in
the warrant agreement set out in Schedule C to this Agreement, in consideration for
the agreement by the Investor to enter into this Agreement to subscribe for the
Convertible Preferred Shares (the “Warrant Agreement”).






The aggregate subscription price of the 360,589,053 Convertible Preferred Shares
subscribed hereunder (the “Initial Convertible Preferred Shares”) shall be US$250
million based on an exchange rate of US$1=HK$7.7743 (the “Aggregate Subscription
Price”). Unless the context otherwise requires, the Initial Convertible Preferred
Shares and the Warrants subscribed for shall be referred to herein as the “Securities”.



     B. The Company and the Investor are executing and delivering this Agreement in
reliance upon the exemption from securities registration under the U.S. Securities Act of 1933, as
amended (the “1933 Act”) afforded by Regulation S (“Regulation S”) as promulgated by the United
States Securities and Exchange Commission (the “SEC”) under the 1933 Act.



     NOW, THEREFORE, the Company and the Investor hereby agree as follows:



 









 






	 	1.	 	SUBSCRIPTION OF THE INITIAL CONVERTIBLE PREFERRED SHARES AND THE WARRANTS




Subscription of the Initial Convertible Preferred Shares. Subject to the satisfaction or
waiver of the conditions set forth in Sections 5, 6 and 7 below, the Company shall issue to the
Investor, and the Investor shall subscribe for, on the Closing Date (as defined in Section 1(b)(i)
below), 360,589,053 Initial Convertible Preferred Shares and 72,117,810 Warrants (the “Closing”).




          (a) Subscription Price. The Aggregate Subscription Price for the Initial Convertible
Preferred Shares shall be US$250 million.




          (b) Closing.




               (i) Date and Time. The date and time of the Closing (the “Closing Date”) shall
be 10:00 a.m., Hong Kong time, on such date as is specified by the Company and the Investor, which
date shall be no later than the first Business Day after the satisfaction or waiver of the
conditions to the Closing set forth in Sections 5, 6 and 7 below, at the offices of Slaughter and
May, 47th Floor, Jardine House, One Connaught Place, Central, Hong Kong or at such other time, date
and location as is mutually agreed in writing by the Company and the Investor.



               (ii) Payment and Delivery. On or before the Closing Date:



                    (A) the Investor shall:




(1) pay the Aggregate Subscription Price to the Company for the
Initial Convertible Preferred Shares to be issued to the Investor at
the Closing, by electronic bank transfer, in immediately available
funds. The payment shall be made to the bank account, bank and bank
address as specified by the Company in writing prior to the Closing
Date; and




(2) deliver to the Company the Warrant Agreement duly executed by
the Investor;



                    (B) the Company shall deliver to the Investor:




	 	(1)	 	certificates in respect of the
Initial Convertible Preferred Shares, respectively, duly
executed on behalf of the Company and registered in the name of
the Investor;
	 
	 	(2)	 	a certified register of members
of the Convertible Preferred Shares of the Company, reflecting
the Investor’s ownership of the relevant Convertible Preferred
Shares, respectively;





 - 2 - 









 






	 	(3)	 	copies of the board resolutions
of the Company approving the entering into and execution of this
Agreement and all transactions contemplated herein;
	 
	 	(4)	 	a copy of the resolution of the
shareholders of the Company pursuant to Section 5(a) below;
	 
	 	(5)	 	a certificate, executed on behalf
of the Company by the Secretary of the Company and dated as of
the Closing Date, as to (i) the resolutions consistent with
Section 3A(b) as adopted by the Board, and (ii) the Articles, in
the form attached hereto as Schedule B;
	 
	 	(6)	 	a certificate, executed on behalf
of the Company by an authorised officer of the Company and dated
as of the Closing Date, as to the conditions precedent set forth
in Section 7(b) and (d) hereof;
	 
	 	(7)	 	an opinion of Conyers Dill &
Pearman, Cayman Islands counsel to the Company, in a form
reasonably satisfactory to the Investor, covering due
authorisation, valid issuance of shares, capitalisation opinion,
no governmental restrictions and no conflicts with law or
charter documents and legality and enforceability of the rights
of the Convertible Preferred Shares;
	 
	 	(8)	 	an opinion of Slaughter and May,
Hong Kong counsel to the Company, in a form reasonably
satisfactory to the Investor, covering the enforceability of
this Agreement and the approval by The Stock Exchange of Hong
Kong Limited (the “SEHK”) of listing of the ordinary shares of
par value US$0.0004 each of the Company (the “Common Shares”)
issuable upon conversion of the Initial Convertible Preferred
Shares (including those Common Shares issuable as a result of
any adjustment to the conversion rate pursuant to the rights of
the Convertible Preferred Shares as set out in Schedule A);
	 
	 	(9)	 	an opinion of M & A Law Firm, the
People’s Republic of China (the “PRC”) counsel to the Company,
in a form reasonably satisfactory to the Investor, covering
compliance with PRC laws; and
	 
	 	(10)	 	the Warrant Agreement duly
executed by the Company and the certificate for the Warrants.





 - 3 - 









 






	 	2.	 	INVESTOR’S REPRESENTATIONS AND WARRANTIES.





               The Investor hereby represents and warrants to the Company that:



          (a) Regulation S.




               (i) The Investor (A) is domiciled and has its principal place of business outside the
United States, (B) certifies that it is not a U.S. Person as defined under Rule 902 of Regulation S
and is not acquiring the Securities for the account or benefit of any U.S. Person, (C) at the time
of offering to the Investor and communication of the Investor’s order to subscribe for the
Securities and at the time of the Investor’s execution of this Agreement, the Investor was located
outside the United States, and (D) at the time of the Closing the Investor, or persons acting on
the Investor’s behalf in connection therewith, will be located outside the United States.



               (ii) The Investor has been advised and acknowledges that: (A) the Securities issued
pursuant to this Agreement and the Warrant Agreement have not been, and when issued, will not be
registered under the 1933 Act or the securities laws of any state of the United States, (B) in
issuing the Securities to the Investor pursuant hereto, the Company is relying upon the exemption
from registration provided by Regulation S of the 1933 Act, and (C) it is a condition to the
availability of the Regulation S safe harbor that the Securities not be offered or sold in the
United States or to a U.S. Person until the expiration of a period of 40 days after the Closing
Date (the “Distribution Compliance Period”).



               (iii) The Investor acknowledges and covenants that until the expiration of the
Distribution Compliance Period: (A) it and its agents or representatives have not and will not
solicit offers to buy, offer for sale or sell any of the Securities or any beneficial interest
therein in the United States or to or for the account of a U.S. Person, and (B) notwithstanding the
foregoing, prior to the expiration of the Distribution Compliance Period, the Securities may be
offered and sold by the holder thereof only if such offer and sale is made in compliance with the
terms of this Agreement and either, (X) the offer or sale is within the United States or to or for
the account of a U.S. Person and pursuant to an effective registration statement, Rule 144
promulgated under the 1933 Act or an exemption from the registration requirements of the 1933 Act,
or (Y) the offer and sale is outside the United States and to other than a U.S. Person. The
foregoing restrictions are binding upon subsequent transferees of the Securities, except for
transferees pursuant to an effective registration statement. The Investor agrees that after the
Distribution Compliance Period, the Securities may be offered or sold within the United States or
to or for the account of a U.S. Person only in accordance with this Agreement and pursuant to
applicable securities laws.



               (iv) The Investor hereby acknowledges that during the Distribution Compliance Period,
no deposit of the Securities issued hereunder will be accepted into its American Depositary Shares
(“ADS”) program, and the Securities may not be offered or sold in the United States or to U.S.
Persons unless the Securities are registered under the 1933 Act, or an exemption from the
registration requirements of the 1933 Act is available. The Investor further acknowledges that,
for so long as the Securities are held by “affiliates” within the meaning of Rule 144(a)(1) under
the 1933 Act or are “restricted securities” within the meaning of Rule 144(a)(3) under the 1933
Act, the Securities will not be eligible for deposit under any unrestricted depositary receipt
facility.



 - 4 - 









 





          (b) No Public Sale or Distribution. Subject to the potential transfer to the
Permitted Transferee (as defined in Section 4(e)(iii)), the Investor is acquiring the Securities
for its own account and not with a view towards, or for resale in connection with, the public sale
or distribution thereof, except pursuant to sales registered or exempted under the 1933 Act. The
Investor does not presently have any agreement or understanding, directly or indirectly, with any
Person to distribute any of the Securities. “Person” means an individual, a limited liability
company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization or
a government or any department or agency thereof.




          (c) Reliance on Exemptions. The Investor understands that the Securities are being
offered and sold to it in reliance on specific exemptions from the registration requirements of
United States federal and state securities laws and that the Company is relying upon the truth and
accuracy of, and the Investor’s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Investor set forth herein in order to determine the
availability of such exemptions and the eligibility of the Investor to acquire the Securities.




          (d) Investment Risk; Knowledge and Experience. The Investor recognizes that its
investment in the Securities involves a high degree of risk, and the Investor has considered
whether an investment in the Securities is appropriate for the Investor. In this regard, the
Investor has such knowledge and experience in financial and business matters that it is capable of
evaluating the risks and merits of prospective investment in the Securities.




          (e) Transfer or Resale. The Investor understands that: (i) the Securities have not
been and are not being registered under the 1933 Act or any state securities laws, and may not be
offered for sale, sold, assigned or transferred within the United States or to or for the account
or benefit of a U.S. Person unless (A) subsequently registered thereunder, (B) the Investor shall
have delivered to the Company an opinion of counsel, in form, scope and substance reasonably
acceptable to the Company, to the effect that such Securities to be sold, assigned or transferred
may be sold, assigned or transferred pursuant to an exemption from such registration, or (C) the
Investor provides the Company with reasonable assurance that such Securities can be sold, assigned
or transferred pursuant to Rule 144 or Rule 144A promulgated under the 1933 Act, as amended, (or a
successor rule thereto) (collectively, “Rule 144”); (ii) any sale of the Securities made in
reliance on Rule 144 may be made only in accordance with the terms of Rule 144 and further, if Rule
144 is not applicable, any resale of the Securities under circumstances in which the seller (or the
Person through whom the sale is made) may be deemed to be an underwriter (as that term is defined
in the 1933 Act) may require compliance with some other exemption under the 1933 Act or the rules
and regulations of the SEC thereunder; and (iii) neither the Company nor any other Person is under
any obligation to register the Securities under the 1933 Act or any state securities laws or to
comply with the terms and conditions of any exemption thereunder.




          (f) Legends. The Investor understands that the certificates or other instruments
representing the Securities, until such time as the resale of the Securities have been registered
under the 1933 Act, shall bear any legend as required by the “blue sky” laws of any state and a
restrictive legend in substantially the following form (and a stop-transfer order may be placed
against transfer of such stock certificates):







 - 5 - 









 









“THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE ACT, AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE
ACCOUNT OR BENEFIT OF, U.S. PERSONS, EXCEPT AS SET FORTH BELOW. BY ITS ACQUISITION
HEREOF, THE HOLDER, IF NOT A U.S. PERSON: (1) REPRESENTS THAT IT IS NOT A U.S.
PERSON AND IS ACQUIRING THESE SHARES IN AN OFFSHORE TRANSACTION; (2) AGREES THAT IT
WILL NOT RESELL OR OTHERWISE TRANSFER THESE SHARES EXCEPT (A) TO THE COMPANY OR ANY
SUBSIDIARY THEREOF, (B) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
ACT, (C) INSIDE THE UNITED STATES, TO A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE
WITH RULE 144A UNDER THE ACT, (D) INSIDE THE UNITED STATES, TO AN ACCREDITED
INVESTOR THAT, PRIOR TO SUCH TRANSFER, FURNISHES TO THE COMPANY A SIGNED LETTER
CONTAINING CERTAIN REPRESENTATIONS AND AGREEMENTS RELATING TO THE RESTRICTIONS ON
TRANSFER OF THESE SHARES (THE FORM OF WHICH LETTER CAN BE OBTAINED FROM THE
COMPANY), (E) OUTSIDE THE UNITED STATES, IN AN OFFSHORE TRANSACTION IN COMPLIANCE
WITH RULES 904 AND 905 UNDER THE ACT, OR (F) PURSUANT TO THE EXEMPTION FROM
REGISTRATION PROVIDED BY RULE 144 UNDER THE ACT (IF AVAILABLE); AND (3) EXCEPT FOR
THE RESALE OR TRANSFER AS DESCRIBED IN CLAUSES 2(A), (B), (E) AND (F), AGREES THAT
IT WILL, IF APPLICABLE, GIVE EACH PERSON TO WHOM THESE SHARES ARE TRANSFERRED A
NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND. IN CONNECTION WITH ANY TRANSFER
OF THESE SHARES PURSUANT TO CLAUSES (2)(C), (D) OR (F) ABOVE, THE HOLDER MUST, PRIOR
TO SUCH TRANSFER, FURNISH TO THE COMPANY SUCH CERTIFICATIONS, LEGAL OPINIONS, OR
OTHER INFORMATION AS THE COMPANY MAY REASONABLY REQUIRE TO CONFIRM THAT SUCH
TRANSFER IS BEING MADE PURSUANT TO AN EXEMPTION OR IN A TRANSACTION NOT SUBJECT TO
THE REGISTRATION REQUIREMENTS OF THE ACT. AS USED HEREIN, THE TERMS ‘OFFSHORE
TRANSACTION’, ‘UNITED STATES’, AND ‘U.S. PERSON’ HAVE THE MEANING GIVEN TO THEM BY
REGULATION S UNDER THE ACT.”



          (g) Validity; Enforcement. The Investor is duly organised, validly existing and in
good standing under the laws of its jurisdiction of formation, and has all requisite corporate
power and authority to enter into and perform this Agreement and consummate the transactions
contemplated hereby. This Agreement has been duly and validly authorised, executed and delivered on
behalf of the Investor and shall constitute the legal, valid and binding obligations of the
Investor enforceable against the Investor in accordance with its terms, except as such
enforceability may be limited by general principles of equity or to applicable bankruptcy,
insolvency, reorganisation, moratorium, liquidation and other similar laws relating to, or
affecting generally, the enforcement of applicable creditors’ rights and remedies.







 - 6 - 









 








          (h) No Conflicts. The execution, delivery and performance by the Investor of this
Agreement and the consummation by the Investor of the transactions contemplated hereby will not (i)
result in a violation of the organisational or constitutional documents of the Investor, (ii)
conflict with, or constitute a default (or an event which with notice or lapse of time or both
would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture or instrument to which the Investor is a party, or
(iii) result in a violation of any law, rule, regulation, order, judgment or decree (including
federal and state securities laws) applicable to the Investor, except in the case of clauses (ii)
and (iii) above, for such conflicts, defaults, rights or violations which would not, individually
or in the aggregate, reasonably be expected to have a material adverse effect on the ability of the
Investor to perform its obligations hereunder; and no authorisation, approval, consent and license
from any supranational, national, state, municipal, local or foreign government, any
instrumentality, subdivision, court, administrative agency or commission or other governmental
authority or regulatory body or instrumentality, or any quasi-governmental or private body
exercising any regulatory, taxing, importing or other governmental or quasi-governmental authority
(a “Governmental Entity”) is required for the entering into by the Investor of this Agreement and
the performance by the Investor of its obligations under this Agreement, except for such as have
already been obtained and are in full force and effect.




          (i) Brokers and Finders. Subject to Section 4(d), no Person will have, as a result of
the transactions contemplated by the Transaction Documents (as defined in Section 3A(b) below), any
valid right, interest or claim against or upon the Company for any commission, fee or other
compensation pursuant to any agreement, arrangement or understanding with a placement agent entered
into by or on behalf of the Investor.




          (j) Acknowledgement. The Investor acknowledges and agrees that the foregoing
representations, warranties, covenants and acknowledgments are made by it with the intention that
they may be relied upon by the Company. The Investor further agrees that by accepting delivery of
the Initial Convertible Preferred Shares at the Closing Date, it shall be representing and
warranting that the foregoing representations and warranties are true and correct as at the Closing
Date with the same force and effect as if they had been made by the Investor at the Closing Date.




          (k) Ownership. The Investor is a wholly-owned subsidiary of China Investment
Corporation.





	 	3.	 	A. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.





     The Company represents and warrants to the Investor that, except as set forth in its Public
Documents (as defined in Section 3A(j) below) (excluding disclosures of non-specific risks faced by
the Company and its subsidiaries (the “Group”) included in any forward-looking statement,
disclaimer, risk factor disclosure or other similarly non-specific statements that are similarly
predictive or forward-looking in nature; provided, however that (i) any historical facts related to
the Group and (ii) any specific exposure or effect faced by the Group emanating from specifically
disclosed facts contained within any such disclosure shall be deemed disclosed for purposes of the
representations and warranties set forth in this Article 3A):



 - 7 - 









 





          (a) Organisation and Qualification. The Company is a corporation duly incorporated
and validly existing in good standing under the laws of the jurisdiction in which it is
incorporated, and has the requisite corporate power and authorisation to own its properties and to
carry on its business as now being conducted. The Company is duly qualified as a foreign
corporation to do business and is in good standing in every jurisdiction in which its ownership of
property or the nature of the business conducted by it makes such qualification necessary, except
to the extent that the failure to be so qualified or be in good standing would not reasonably be
expected to have a Material Adverse Effect. As used in this Agreement, “Material Adverse Effect”
means (1) any material adverse effect on (i) the business, properties, assets, liabilities,
operations, results of operations or financial condition of the Company and its subsidiaries, taken
as a whole, or (ii) the authority or ability of the Company to perform its obligations under the
Transaction Documents (as defined in Section 3A(b) below) or (2) the delisting of the Common Shares
from the SEHK and the American Depository Receipts over the Common Shares from the NYSE; provided,
however, that for purposes of clause (i) above, in no event shall any of the following exceptions,
alone or in combination with the other enumerated exceptions below, be deemed to constitute, nor
shall be taken into account in determining whether there has been or will be, a Material Adverse
Effect: (A) any effect resulting from compliance with the terms and conditions of, or from the
announcement of the transactions contemplated by this Agreement, (B) any effect that results from
changes affecting any of the industries in which the Company operates generally or the economy
generally, (C) any effect that results from changes affecting general worldwide economic or capital
market conditions, provided that any such changes in (B) and (C) do not substantially
disproportionately affect the Company in any material respect (as otherwise such changes in (B) and
(C) shall be regarded as having a Material Adverse Effect under this Section 3A(a)), or (D) any
change in the Company’s stock price or trading volume, in and of itself, primarily resulting from
any of the effects or changes described in the foregoing clauses (A), (B) or (C). Each subsidiary
of the Company has been duly organised and is validly existing in good standing under the laws of
its jurisdiction of organisation except to the extent that the failure to be in good standing would
not reasonably be expected to have a Material Adverse Effect.




          (b) Authorisation; Enforcement; Validity. Other than the approvals set out in Section
5(a) below, the Company has the requisite corporate power and authority to enter into and perform
its obligations under this Agreement and each of the other agreements entered into by the parties
hereto in connection with the transactions contemplated by this Agreement and the Warrant Agreement
(collectively, the “Transaction Documents”) and to issue the Securities in accordance with the
terms hereof and thereof. The execution and delivery of the Transaction Documents by the Company
and the consummation by the Company of the transactions contemplated hereby and thereby, including,
without limitation, the issuance of the Securities has been duly authorised by the Board and no
further filing, consent or authorisation is required by the Board, except for the filing, consent
or authorisation in connection with the satisfaction of the conditions in Section 5(a) below and
any required filings regarding the issuance or listing of additional securities with The Stock
Exchange of Hong Kong Limited (the “SEHK”) or the New York Stock Exchange (the “NYSE”). This
Agreement and the other Transaction Documents when duly executed and delivered by the Company
constitute the legal, valid and binding obligations of the Company, enforceable against the Company
in accordance with their respective terms, except as such enforceability may be limited by general
principles of equity or applicable bankruptcy, insolvency, reorganisation, moratorium, liquidation
or similar laws relating to, or affecting generally, the enforcement of applicable creditors’
rights and remedies.








 - 8 - 









 








          (c) Issuance of Securities. The Securities are duly authorised and, when issued and
paid for in accordance with the terms hereof, shall be validly issued and free from all preemptive
or similar rights, taxes, liens and charges with respect to the issue thereof. The Convertible
Preferred Shares issued or to be issued under this Agreement and upon the exercise of the Warrants
shall be fully paid with the holders being entitled to all rights accorded to a holder of the
Convertible Preferred Shares. Assuming the accuracy of each of the representations and warranties
set forth in Section 2 of this Agreement, the offer and issuance by the Company of the Securities
is exempt from registration under the 1933 Act.




          (d) No Conflicts. The execution, delivery and performance of the Transaction Documents
by the Company and the consummation by the Company of the transactions contemplated hereby and
thereby (including, without limitation, the issuance of the Securities) will not (i) result in a
violation of the Articles, (ii) conflict with, or constitute a default (or an event which with
notice or lapse of time or both would become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to
which the Company or any of its subsidiaries is a party, or (iii) subject to the terms of this
Agreement, result in a violation of any law, rule, regulation, order, judgment or decree (including
the Hong Kong Codes on Takeovers and Mergers, foreign, U.S. federal and state securities laws and
regulations and the rules and regulations of the SEHK or of the NYSE applicable to the Company or
by which any property or asset of the Company or any of its subsidiaries is bound or affected),
except in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or
violations which would not reasonably be expected to result in a Material Adverse Effect.




          (e) No Consents or Approvals. Save as otherwise disclosed to the Investor in the
disclosure letter from the Company to the Investor dated the date hereof (the “Disclosure Letter”),
the Company is not required to obtain any consent, approval, authorisation or order of, or make any
filing or registration with or give prior notification to (i) any court, Governmental Entity or any
regulatory or self-regulatory agency in order for it to execute, deliver or perform any of its
obligations under or contemplated by the Transaction Documents or (ii) any third party pursuant to
any agreement, indenture or instrument to which the Company or any of its subsidiaries is a party
(except for such requirements in either (i) or (ii) above the non-fulfilment of which would not
result in a Material Adverse Effect), in each case in accordance with the terms hereof or thereof
other than such as have been made or obtained, and except for the filings or notifications in
connection with the satisfaction of the conditions set forth in Section 5(a) below and any required
filings or notifications regarding the issuance or listing of additional securities with the SEHK
or the NYSE or such consents as will be obtained by the Company on or before Closing. The Company
has no knowledge of any facts or circumstances that might prevent the Company from obtaining or
effecting any of the filings or notifications described in the preceding sentence. The Company is
not in violation of the listing requirements of the SEHK or the NYSE and has no knowledge of any
facts that would reasonably lead to delisting or suspension of its Common Shares from the SEHK or
of its American depository receipts from the NYSE in the foreseeable future, apart from such
suspension from SEHK and/or NYSE in connection with or resulting from the entering into of this
Agreement. As used herein, “knowledge” shall mean actual knowledge of the executive officers (as
defined in Rule 405 under the 1933 Act) of the Company after due inquiry.




          (f) No Directed Selling Efforts. Neither the Company nor any of its affiliates or any
other person acting on its or their behalf has engaged or will engage in any directed selling
efforts within the






 - 9 - 









 







meaning of Regulation S under the 1933 Act, as amended, and all such persons have complied
with the offering requirements of Regulation S under the 1933 Act.




          (g) Foreign Private Issuer. The Company is a “foreign private issuer” (as such term is
defined in the rules and regulations under the 1933 Act and the U.S. Securities Exchange Act of
1934 (“1934 Act”), as amended).




          (h) No General Solicitation; Agent. Neither the Company, nor any of its affiliates,
nor any Person acting on its or their behalf, has engaged in any form of general solicitation or
general advertising (within the meaning of Regulation D) in connection with the offer or sale of
the Securities. The Company acknowledges that it has engaged Bank of America Merrill Lynch as
financial advisor (the “Agent”) in connection with the issue of the Securities. Other than the
Agent, no Person will have, as a result of the transactions contemplated by the Transaction
Documents, any valid right, interest or claim against or upon the Company or the Investor for any
commission, fee or other compensation pursuant to any agreement, arrangement or understanding with
a placement agent entered into by or on behalf of the Company.




          (i) No Integrated Offering. Assuming the accuracy of the Investor’s representations
and warranties set forth in Section 2 hereof, none of the Company, any of its affiliates, or any
Person acting on their behalf has, directly or indirectly, made any offers or sales of any security
or solicited any offers to buy any security, under circumstances that would require registration of
the issuance of any of the Securities under the 1933 Act, whether through integration with prior
offerings or otherwise, or cause the offering of Securities hereunder to require approval of
shareholders of the Company for purposes of any applicable shareholder approval provisions (except
those set out in Section 5(a) below), including, without limitation, under the rules and
regulations of the SEHK and the NYSE. None of the Company, their affiliates and any Person acting
on their behalf will take any action or steps referred to in the preceding sentence that would
require registration of the issuance of any of the Securities under the 1933 Act or cause the
offering of the Securities to be integrated with other offerings for purposes of any such
applicable shareholder approval provisions.




          (j) Public Documents. The Company has timely filed all reports, schedules, forms,
statements and other documents required to be filed by it with the SEC pursuant to the reporting
requirements of the 1934 Act or with the SEHK and has timely issued all announcements, returns,
notices, financial statements and circulars required to be issued by it by the SEHK or the NYSE
(all of the foregoing filed or announced prior to the date of this Agreement and all exhibits
included therein and financial statements, notes and schedules thereto and documents and
incorporated by reference therein being hereinafter referred to as the “Public Documents”). As of
their respective filing or issuance dates, the Public Documents complied in all material respects
with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated
thereunder and the rules and regulations of the SEHK and the NYSE, as applicable, to the respective
Public Documents, and, other than as corrected or clarified in a subsequent Public Document, none
of the Public Documents, at the time they were filed or issued, contained any untrue statement of a
material fact or omitted to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they were made,
not misleading.








 - 10 - 









 








          (k) Financial Statements. The consolidated financial statements (including any related
notes thereto) included or incorporated by reference in the Public Documents fairly presented in
all material respects the consolidated financial position of the Company and its consolidated
subsidiaries as of the dates indicated therein and the consolidated results of their operations for
the periods specified therein, other than as corrected or clarified in a subsequent Public
Document. Such financial statements were prepared in material conformity with accounting
principles generally accepted in the United States of America (“GAAP”) applied on a materially
consistent basis (except as may be noted therein). The financial statements of the Company as of
and for the year ended December 31, 2010 included in the Public Documents are hereinafter referred
to as the “Results”. Since December 31, 2010, the Company and its subsidiaries do not have any
material liabilities or obligations required under GAAP to be set forth on a consolidated balance
sheet (accrued, absolute, contingent or otherwise), other than (i) liabilities or obligations that
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect, and (ii) liabilities incurred since December 31, 2010 in the ordinary course of business
consistent with past practices and any liabilities incurred pursuant to this Agreement.




          (l) Internal Controls and Procedures. The Company maintains disclosure controls and
procedures as such terms are defined in, and required by, Rule 13a-15 and Rule 15d-15 under the
1934 Act. Such disclosure controls and procedures are effective to ensure that all material
information required to be disclosed by the Company in the reports that it files or furnishes under
the 1934 Act is recorded, processed, summarised and reported within the time periods specified in
the rules and forms of the SEC. The Company maintains a system of internal controls over financial
reporting sufficient to provide reasonable assurance that (i) transactions are executed in
accordance with management’s general or specific authorisations; and (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with GAAP. The Company’s
management has completed an assessment of the effectiveness of the Company’s system of internal
controls over financial reporting for the fiscal year ended December 31, 2010 in compliance with
the requirements of Section 404 of the Sarbanes-Oxley Act, and such assessment concluded that such
controls were effective and the Company’s independent registered accountant has issued (and not
subsequently withdrawn or qualified) an attestation report concluding that the Company maintained
effective internal control over financial reporting as of December 31, 2010. As of the date
hereof, to the knowledge of the Company, there is no reason that its chief executive officer and
chief financial officer will not be able to give the certifications and attestations required
pursuant to the rules and regulations adopted pursuant to Section 404 of the Sarbanes-Oxley Act of
2002, without qualification, when next due.




          (m) No Material Adverse Effect. Since December 31, 2010, no event or circumstance has
occurred that, individually or in the aggregate, has had or could reasonably be expected to have a
Material Adverse Effect. Neither the Company nor any of its subsidiaries has taken any steps to
seek protection pursuant to any bankruptcy law nor does the Company have any knowledge or reason to
believe that its creditors intend to initiate involuntary bankruptcy proceedings or any fact which
would reasonably lead a creditor to do so.




          (n) Litigation. Save as disclosed in the Disclosure Letter, there are no claims,
suits, investigation, actions or proceedings pending or, to the Company’s knowledge, threatened
against the Company or any of its subsidiaries or, to the best of the knowledge of the Company, any
of their respective






 - 11 - 









 







directors, officers, employees (such employees performing managerial functions in departments
of the Company concerning research and development, manufacturing, finance and marketing) or
properties before any court, governmental department, commission, agency, instrumentality or
authority, or any arbitrator that seeks to restrain or enjoin the consummation of the transactions
contemplated by this Agreement or which could reasonably be expected, to have, individually or in
the aggregate, a Material Adverse Effect. No existing facts or developments related to
the Company’s pending litigation, taken as a whole, have been omitted from the Public Documents
that would reasonably be expected to have a Material Adverse Effect (it being understood that this
representation and warranty shall not be taken as a guarantee as to the outcome of such
litigation).




          (o) Compliance with Applicable Laws. Save as disclosed in the Disclosure Letter, to
the best of the knowledge of the Company, the Company and each of its subsidiaries have conducted
their businesses in compliance with all applicable federal, state and foreign laws, regulations and
applicable stock exchange requirements, except where the failure to be in compliance could not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. The
Company will use its best efforts to maintain its corporate existence and conduct its business in
compliance in all respects with all applicable laws, regulations and rules so as not to cause a
Material Adverse Effect to occur on the Company.





     Save as disclosed in the Disclosure Letter, the Company and each of its subsidiaries have all
permits, licenses, authorisations, orders and approvals of, and have made all filings, applications
and registrations with, any Governmental Entities that are required in order to carry on their
business as presently conducted, except where the failure to have such permits, licenses,
authorisations, orders and approvals or the failure to make such filings, applications and
registrations, individually or in the aggregate, could not reasonably be expected to have a
Material Adverse Effect; and all such permits, licenses, certificates of authority, orders and
approvals are in full force and effect and, to the knowledge of the Company, no suspension or
cancellation of any of them is threatened, and all such filings, applications and registrations are
current, except where such absence, suspension or cancellation, individually or in the aggregate,
could not reasonably be expected to have a Material Adverse Effect.



          (p) Equity Capitalisation. As of 31 March, 2011, the authorised share capital of the
Company consists of (A) 50,000,000,000 Common Shares, of which as of such date, 27,396,956, 059
shares are issued, (as at 31 March, 2011, 1,340,050,102 shares may be issued pursuant to the
Company’s employee incentive plan, and 488,730 and 759,521,230 shares may be issued pursuant to
outstanding warrants held by ZXZY Inc. and Taiwan Semiconductor Manufacturing Company Ltd.,
respectively) and no agreement or commitment outstanding which calls for the allotment or issue or
accords to any person the right to call for the allotment or issue of any shares (including shares
issued pursuant to securities exercisable or exchangeable for, or convertible into, or agreements
relating to the issuance of Common Shares), and (B) 5,000,000,000 Preferred Shares, of which none
are issued. All of such issued shares have been validly issued and are fully paid. Save as
disclosed in the Disclosure Letter and other than those set out above and pursuant to this
Agreement, the Warrant Agreement, or any rights created as a consequence of this Agreement or the
Warrant Agreement (including without limitation any pre-emption rights of the existing shareholders
of the Company as disclosed in the Disclosure Letter) to subscribe for securities in






 - 12 - 









 







the Company, there are no outstanding securities issued by the Company or its subsidiaries
(including shares issuable pursuant to securities exercisable or exchangeable for, or convertible
into, or agreements related to the issuance of Common Shares or preferred shares (together,
“Shares”)), or warrants, rights or options to purchase Shares from the Company or its subsidiaries,
nor are there any agreement, arrangement or commitment outstanding which calls for the allotment or
issue or accords to any person the right to call for the allotment or issue of any Shares
(including Shares issuable pursuant to securities exercisable or exchangeable for, or convertible
into, or agreements relating to the issuance of Shares).




          The Company, on or prior to the Closing Date, will have, and undertakes thereafter to use its
best efforts to keep from time to time, sufficient authorised share capital to satisfy the issue
of (i) the Initial Convertible Preferred Shares and the Convertible Preferred Shares issuable under
the Warrants, (ii) such number of new Common Shares as would be required to be issued on conversion
in full of the Initial Convertible Preferred Shares and the Convertible Preferred Shares issuable
under the Warrants (subject to adjustment to the conversion rate pursuant to the rights of the
Convertible Preferred Shares as set out in Schedule A); (iii) subject to compliance with applicable
laws and regulations (including without limitation the rules of the SEHK in respect of
shareholders’ approval), such additional Convertible Preferred Shares (the “Additional Convertible
Preferred Shares”) pursuant to Section 4(i) below and such number of new Common Shares as would be
required to be issued on conversion in full of the Additional Convertible Preferred Shares; and
(iv) subject to compliance with applicable laws and regulations (including without limitation the
rules of the SEHK in respect of shareholders’ approval), such number of Relevant Securities (as
defined in Section 4(i)(i) below) pursuant to Section 4(i) below.




          (q) Information provided. All information given in connection with the transactions
contemplated by this Agreement by the Company or on its behalf by the Company’s advisers, to the
Investor or the Investor’s advisers, relating to the Company, its subsidiaries or their respective
business, activities, affairs, or assets or liabilities (including all documents attached thereto)
was, when given, and is now accurate in all material respects and not misleading in any material
respect, and there is no material omission that would render the information given misleading in
any material respect, provided that nothing herein shall constitute any obligation on the Company
to disclose any information over and above what is required to be disclosed by the Company under
the requirements of applicable laws and regulations (including, but not limited to, the Hong Kong
Listing Rules) or requirements of regulatory bodies (including, but not limited to the SEHK and the
SEC).




          (r) Ownership of assets. Save as disclosed in the Disclosure Letter, as may be
updated by the Company in writing prior to Closing, so far as the Company is aware, there are no
mortgages, charges, pledges, liens (other than liens arising in the ordinary course of trading) or
other forms of security or encumbrances, over or affecting the whole or any part of the material
assets of the Company or any of its subsidiaries. Other than as disclosed, the Company and its
subsidiaries have title to all properties and to all assets necessary to conduct the business now
operated by them in each case few from liens, encumbrances and title defects that would materially
affect the value thereof or materially interfere with the use made or to be made thereof by them
and any real property or building held under lease by the Company or any of its subsidiaries are
held by it under valid, existing and enforceable leases, in each case except to the extent that any
failure of the above would not have a Material Adverse Effect.








 - 13 - 









 








          (s) Intellectual Property. To the knowledge of the Company, the Company owns or
possesses sufficient legal rights including but not limited to trade secrets, licenses, trade mark,
confidential information and proprietary rights and manufacturing processes and all copyrights,
mask work rights, all patents and patent rights, as are necessary to the conduct of the business as
now conducted or presently proposed to be conducted by the Company and its subsidiaries, including
but not limited to the manufacturing of such products of 0.13um, 45nm, 90nm, and/or 65nm processes
(or as presently proposed to be conducted on products) by the Company or any of its subsidiaries,
without any known conflict with, or known infringement of, the rights of others except as would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. To
the knowledge of the Company, no products manufactured, marketed or sold (or products proposed to
be manufactured, marketed or sold) by the Company or any of its subsidiaries violates any license
or infringes any intellectual property rights of any other party which could reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect. Notwithstanding the
definition of “knowledge,” the Company has not, nor shall the definition of “knowledge” be
interpreted to require an analysis of the Company’s freedom to operate in a particular field with
respect to ownership and use of intellectual property rights.




          (t) United States Export Control. The Company is in compliance with, and undertakes
to use its reasonable endeavours to comply with, all applicable laws, regulations, practices,
policies, rules and any other governmental requirements of the United States and other countries or
regions in relation to any export or supply of technology, equipment or any information in
connection with the Group’s business operation, the omission of which could reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect.




          (u) Tax Return. Each of the Company and its subsidiaries has duly and timely filed all
tax returns that are required to be filed in all jurisdictions or has duly requested extensions
thereof and has paid all taxes required to be paid by any of them in all jurisdictions and any
related assessments, fines or penalties, except for any such tax, assessment, fine or penalty that
is being contested in good faith and by appropriate proceedings or where the failure to file or
make payment would not, singly or in the aggregate, have a Material Adverse Effect. Adequate
charges, accruals and reserves have been provided for in the Results referred to in Section 3A(k)
in respect of all taxes for all periods as to which the tax liability of the Company or any of its
subsidiaries has not been finally determined or remains open to examination by an applicable taxing
authority.




          (v) Environmental Laws. The Company and its subsidiaries (i) have been and are in
compliance with any and all applicable foreign, national and local laws and regulations relating to
the protection of human health and safety, the environment or hazardous or toxic substances or
wastes, pollutants or contaminants (the “Environmental Laws”), (ii) have received all permits,
licenses or other approvals required of them under applicable Environmental Laws to conduct their
respective businesses and (iii) are in compliance with all terms and conditions of any such permit,
license or approval, except where such non-compliance with Environmental Laws, failure to receive
required permits, licenses or other approvals or failure to comply with the terms and conditions of
such permits, licenses or approvals would not, singly or in the aggregate, have a Material Adverse
Effect on the Company and its subsidiaries taken as a whole.








 - 14 - 









 








          (w) Foreign Corrupt Practices. To the best of the knowledge of the Company, no member
of the Group nor any director, officer, agent, employee (such agent or employee acting under the
direction of the Company) or Affiliate of any member of the Group, has, directly or indirectly,
made or authorised (A) any contribution, payment or gift of funds or property to any official,
employee or agent of any authority, or any candidate for public office, in Hong Kong, the Cayman
Islands, the United States, the PRC or any other jurisdiction, where either the payment or the
purpose of such contribution, payment or gift was, is, or would be prohibited under any applicable
law, rule, or regulation, or (B) any bribe, rebate, payoff, influence payment, kickback or other
unlawful payment to any government officials or employees for the purpose of obtaining favours or
undue influence, and without prejudice to the foregoing, neither any member of the Group nor any
director, officer agent, employee (such agent or employee acting under the direction of the
Company) or Affiliate of any member of the Group, to the best knowledge of the Company, has taken
any action, directly or indirectly, that would result in a violation by such persons of the Foreign
Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder, and the
Company and the other members of the Group have instituted and maintain policies and procedures
designed to ensure compliance with applicable laws relating to anti-bribery in the jurisdictions in
which the Group conducts its business.




          (x) Money Laundering Laws. To the best of the knowledge of the Company, the
operations of each member of the Group are and have been conducted at all times in compliance with
applicable financial recordkeeping and reporting and other requirements of the money laundering
laws of all jurisdictions, including the United States Currency and Foreign Transactions Reporting
Act of 1970, as amended (collectively, the “Money Laundering Laws”), and no action, suit,
proceeding, investigation or inquiry by or before any authority involving any member of the Group
with respect to the Money Laundering Laws is pending or threatened.





	 	3.	 	B. LIMITATIONS ON REPRESENTATIONS AND WARRANTIES.





     The maximum aggregate liability of the Company in respect of all claims made by the Investor
under any of the representations and warranties set out in Section 3A above shall not, whether
individually or in the aggregate, exceed the Aggregate Subscription Price (it being understood that
any assessment of damages shall not include any special, consequential or punitive damages and
shall only be limited to actual damages suffered including any diminution in the value of the
Securities subscribed as a result of any breaches). For the avoidance of doubt, the aforementioned
limitation shall not affect claims made by the Investor pursuant to other agreements between the
Investor and the Company, including but not limited to the subscription agreements referred to
under Section 4(i)(iii) and Section 4(i)(iv) below.




	 	4.	 	COVENANTS.





          (a) Best Efforts. Each party shall use its best efforts to satisfy each of the
covenants and conditions to be satisfied by it as provided in Sections 5, 6 and 7 of this Agreement
on a timely basis.




          (b) Regulatory Filings. The Investor shall use best endeavors to furnish such
information, supply such documents, give such undertakings and do all such acts and things as may
reasonably be






 - 15 - 









 







required by the SEHK and/or any other Governmental Entity in relation to or arising out of the
transactions contemplated hereby.




          (c) Listing. The Company shall use its best efforts to promptly secure the approval
for the issue of the Initial Convertible Preferred Shares the Convertible Preferred Shares issuable
upon the exercise of the Warrants and the Warrants (and, immediately after the Investor elects to
subscribe for the Additional Convertible Preferred Shares pursuant to this Agreement, the
Additional Convertible Preferred Shares) and the listing of, and permission to deal in, all of the
Common Shares to be issued to the Investor upon the conversion of the Initial Convertible Preferred
Shares (and, if the Investor elects to subscribe for the Additional Convertible Preferred Shares
pursuant to this Agreement and/or exercises the Warrants, the Common Shares issuable upon the
conversion of the Additional Convertible Preferred Shares and/or the Convertible Preferred Shares
to be issued pursuant to any exercise of the Warrants) (subject to adjustment to the conversion
rate pursuant to the rights of the Convertible Preferred Shares as set out in Schedule A) on the
SEHK and shall use reasonable best efforts to maintain at all times and from time to time a listing
on SEHK of and permission to deal in all Common Shares issued or to be issued. The Company shall
pay all fees and expenses in connection with satisfying its obligations under this Section 4(c).




          (d) Fees. Each party to this Agreement shall bear its own expenses and the fees
relating to or arising out of the transactions contemplated hereby.




          (e) Lock-Up.




               (i) The Investor (and to the extent any Securities are transferred to the Permitted
Transferee in accordance with the provisions of Section 4(e)(iii), the Permitted Transferee) shall
not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise
transfer or dispose of, directly or indirectly (each a “Disposal”), any of the Initial Convertible
Preferred Shares, any Convertible Preferred Shares issued upon the exercise of the Warrants and any
Additional Convertible Preferred Shares (the “Investor Convertible Preferred Shares”) or the
Warrants subscribed hereunder or any of the Common Shares issuable upon conversion of such
Convertible Preferred Shares or enter into any swap, hedging or other arrangement that transfers to
another, in whole or in part, any of the economic consequences of ownership of any of such
securities (any of the foregoing, a “Transfer”) without the prior written consent of the Company
for a period of two (2) years from the Closing Date (the “Lock-Up Period”), provided that nothing
herein shall restrict the Investor from a Disposal of any of the Investor Convertible Preferred
Shares or the Warrants subscribed hereunder or any of the Common Shares issuable upon conversion of
the Investor Convertible Preferred Shares to the Permitted Transferee and the rights of the
Investor under this Agreement shall not be affected by such Disposal, provided that this paragraph
shall cease to apply if any of Mr. David N.K. Wang (chief executive officer and president of the
Company), Mr. Gary Tseng, Mr. Simon Yang, Mr. Chris Keh-Fei Chi and Mr. Barry Quan, shall not
continue their respective employment with the Company for a minimum period of two (2) years
commencing from the Closing Date, except:



                    (1) as a result of the misconduct of any of the said individuals; or



 - 16 - 









 





                    (2) where the health condition of any of the said individuals is such that the relevant
individual is not able to continue his employment with the Company.



               (ii) The Investor (and, to the extent any Securities are transferred to the Permitted
Transferee in accordance with the provisions of Section 4(e)(iii), the Permitted Transferee) shall
refrain at all times (including with respect to time periods after the expiration of the Lock-Up
Period) from selling the Investor Convertible Preferred Shares and the Warrants or any Common
Shares issued upon conversion of the Investor Convertible Preferred Shares to any person or entity
that in any manner, directly or indirectly, is a Competitor, except:




               (1) in a genuine open market sale where the identity of the purchaser is not known to, and
cannot reasonably be determined by, the Investor or its agent effecting such sale;




               (2) with the written consent of the Board (which shall, for the purposes of this Section
4(e)(ii), exclude the Investor Nominee); or




               (3) accepting an offer (as defined in the Code on Takeovers and Mergers in Hong Kong (the
“Hong Kong Takeovers Code”)) under a general offer for the Company where the offer has become
unconditional (meaning that the offeror has received acceptances in respect of voting rights in the
Company which, together with voting rights acquired or agreed to be acquired before or during the
offer, will result in the offeror and any person acting in concert with it holding more than 50%
(or such other percentage level as contained in the terms of such offer or as otherwise required
from time to time in the Hong Kong Takeovers Code) of the voting rights in the Company), or where
the offeror has become entitled to compulsorily acquire the securities held by the Investor (and/or
the Permitted Transferee) under applicable laws and regulations.



“Competitor” shall mean any entity that provides or that has the capability to provide, directly or
indirectly through any subsidiary or affiliate, semiconductor wafer fabrication or foundry services
to third parties.




               (iii) Notwithstanding the foregoing, the Company hereby agrees that the Investor may,
subject to compliance with the rules (including the Hong Kong Listing Rules), regulations, laws of
Hong Kong and the requirements of the SEHK, transfer all or part of the Investor Convertible
Preferred Shares, the Warrants or the Common Shares issuable upon conversion of the Investor
Convertible Preferred Shares held by it to a wholly-owned subsidiary of China Investment
Corporation (the “Permitted Transferee”) provided, that, as a condition to any such transfer:




	 	(A)	 	the Investor shall inform the Company in
writing of the proposed Transfer to the Permitted Transferee before
effecting it;
	 
	 	(B)	 	the Permitted Transferee shall furnish the
Company with a written agreement in a form reasonably satisfactory to
the Company:






	 	(1)	 	agreeing, as if the Permitted
Transferee was a party to the Transaction Documents, to be bound
by the obligations under the Transaction Documents applicable to
the Securities, including without limitation, the lockup
provisions set forth in




 - 17 - 









 






	 	 	 	Section 4(e) and the public disclosure provisions set forth in
Section 4(f);






	 	(2)	 	giving representations and
warranties to the Company in the form set forth in Section 2(a),
2(b), 2(c), 2(d), 2(e), 2(f), 2(g), 2(h), 2(i), 2(j) and 2(k),
and agree to the provisions set forth in Section 9 (except that
references to the “Investor” shall be replaced with references
to the “Permitted Transferee”), and provided that the terms of
the Confidentiality Agreement (as defined in Section 9(h)) shall
be incorporated fully into such agreement); and
	 
	 	(3)	 	without prejudice to the rights
of the Investor under this Agreement (which rights shall remain
with the Investor not withstanding the Disposal to the Permitted
Transferee), acknowledging that the Permitted Transferee shall
not have any right or understanding or arrangement (whether
formal or informal) to nominate any person as a director of the
Company, or exercise any other rights relating to the Securities
that are not contained in the Memorandum of Association and
Articles of Association of the Company as in effect as of the
Closing Date (the “Articles”) or under any applicable laws;






	 	(C)	 	the Permitted Transferee shall be entitled to
further transfer the Securities to another Permitted Transferee during
the remaining period of the Lock-up Period on the condition that the
provision relating to transfer to “Permitted Transferee” in Section
4(e) shall not have been complied with).





          (f) Public Disclosure. Without limiting any other provision of this Agreement, the
Company and Investor (and to the extent any Securities are Transferred to the Permitted Transferee
in accordance with the provisions of this Section 4(e), the Permitted Transferee), to the extent
permitted by applicable law, will consult with each other before issuance, and provide each other
the opportunity to review, comment upon and concur with, and use all reasonable efforts to agree on
any press release or public statement with respect to this Agreement, the Warrant Agreement and the
transactions contemplated thereunder, and will not (to the extent practicable) issue any such press
release or make any such public statement prior to such consultation and agreement, except as may
be required by law, rules, regulations or any listing agreement with or requirement of the NYSE,
SEHK or any other applicable securities exchange, provided that the disclosing party shall, to the
extent permitted by applicable law, rules, regulations or any listing agreement with or requirement
of the NYSE, SEHK or any other applicable securities exchange and if reasonably practicable, inform
the other parties about the disclosure to be made pursuant to such requirements prior to the
disclosure.




          (g) Conduct of Business. Save as disclosed in this Agreement or any public disclosure
made by the Company prior to the date of this Agreement, or consented in writing by the Investor,
during






 - 18 - 









 







the period from the date of this Agreement and continuing until the earlier of the termination
of this Agreement pursuant to Section 8(a) hereof or the Closing, the Company shall and shall cause
its subsidiaries to, except as expressly permitted by the terms of this Agreement or disclosed in
any public disclosure made by the Company prior to the date of this Agreement, carry on its
business, in all material respects, in the ordinary and normal course and, not (i) undertake any
construction of any new plants and buildings, (ii) enter into any notifiable transactions (as such
term is defined under the Hong Kong Listing Rules) ; (iii) save as required by applicable laws,
rules or regulations, make or propose to make any amendments to its memorandum or articles of
association or (iv) agree to, either verbally or in writing, authorise or approve any of the
foregoing.



For the avoidance of doubt, the Company may continue to be involved in the existing construction of
plants and buildings, as the Board may consider appropriate from time to time.




          (h) Use of Proceeds. The Company shall use the proceeds received from the issue of
the Securities hereunder for the purpose of capital expenditure and debt repayment.




          (i) Pre-emptive Rights.




               (i) If the Company proposes, on or after the date of this Agreement, to issue (the
“Proposed Issue”) (a) any new Common Shares or preferred shares, (b) any securities convertible
into or exchangeable into Common Shares or preferred shares (which preferred shares referred to in
(a) and (b) above carry voting rights in general meetings of the Company) or (c) any warrants or
other rights to subscribe for Common Shares or preferred shares (which preferred shares carry
voting rights in general meetings of the Company) (“Relevant Securities”), the Company shall notify
the Investor in writing of such proposal (an “Issue Notice”). The Issue Notice shall specify the
number and type of Relevant Securities to be offered by the Company and the material terms of the
proposed offer (including the proposed completion date of such issue and the proposed price per
Relevant Security to be paid by the proposed third party purchaser(s)).



               (ii) Subject to sub-paragraph (viii) below, the Investor shall have the right but not
the obligation, at its option, to subscribe for:




               (1) whilst any Investor Convertible Preferred Shares issued to and beneficially held by the
Investor (and/or the Permitted Transferee) remain unconverted, and to the extent that the
percentage (the “Original Percentage”) of the issued share capital of the Company held by the
Investor on a fully-diluted basis through such Investor Convertible Preferred Shares immediately
prior to the Proposed Issue is reduced as a result of the issue of the Relevant Securities (having
taken into account the adjustment (the “Resulting Adjustment”) to the conversion rate of the
Convertible Preferred Shares as a result of the issuance of the Relevant Securities in accordance
with Schedule A), such number of Additional Convertible Preferred Shares (bearing the same
conversion rate as the existing issued Convertible Preferred Shares having reflected the Resulting
Adjustment) so as to enable the Investor to hold, after the issue of the Relevant Securities, a pro
rata portion of the issued share capital of the Company (on a fully-diluted basis) equal to the
Original Percentage. For the purpose of this paragraph, the Warrants and any Convertible Preferred
Shares issuable thereunder shall be disregarded to the



 - 19 - 









 






extent that the Warrants have not been exercised and Convertible Preferred Shares have not
been issued thereunder; and




               (2) to the extent that any of the Investor Convertible Preferred Shares have been converted
and the Investor is holding Common Shares issued as a result of the said conversion (the “Converted
Common Shares”), such number of additional Relevant Securities so as to enable the Investor to
hold, after the issue of the Relevant Securities, a pro rata portion of the Relevant Securities
equal to the percentage of the issued share capital of the Company represented by the Converted
Common Shares then beneficially owned by the Investor immediately prior to the issuance of the
Relevant Securities,




by giving written notice to the Company of the exercise of this right within ten (10) Business Days
(as defined below) of the giving of the Issue Notice. If such notice is not given by the Investor
within such ten (10) Business Days, the Investor shall be deemed to have elected not to exercise
its rights under this Section 4(i)(ii) with respect to the issuance described in that specific
Issue Notice. The parties acknowledge that any rights of the Investor to subscribe for pursuant
to this Section 4(i)(ii) will lapse if completion thereof does not occur simultaneously with the
completion of the issue of Relevant Securities by the Company to third party purchaser(s) or at
such other time and place as shall be mutually agreed by the Company and the Investor (which
agreement shall not be unreasonably withheld), provided that if the reason for the Investor’s
failure to complete by the time specified above is solely due to a delay of the Governmental Entity
in granting the relevant authorisations, approvals, permits, qualifications or exemptions, the
Investor shall notify the Company in writing at least seven (7) days prior to the completion of the
issue of the Relevant Securities to extend the completion date for the Investor’s subscription to a
date within three (3) months or such other reasonable period as may be mutually agreed between the
parties following the completion of the issue of the Relevant Securities, after such period the
right of the Investor to subscribe for securities pursuant to this Section 4(i)(ii) shall lapse. A
notice given by the Investor pursuant to this section shall be irrevocable.



               (iii) For the purpose of Section 4(i)(ii)(1), the subscription price of each
Additional Convertible Preferred Share to be issued to the Investor shall be equal to the
subscription price of each Convertible Preferred Share issued at the Closing. The Investor shall
enter into a subscription agreement for the subscription of the Additional Convertible Securities
containing the same terms and conditions as the agreement entered into by the Company with the
relevant investor(s) or the relevant issue documents (where applicable) in relation to the issue of
the Relevant Securities.



               (iv) For the purpose of Section 4(i)(ii)(2), the subscription price and other terms
and conditions applicable to the issue of the Relevant Securities to the Investor shall be the same
as those applicable to the Proposed Issue. The Investor shall enter into a subscription agreement
for the subscription of the Relevant Securities containing the same terms and conditions as the
agreement to be entered into by the Company with the relevant investor(s) or the relevant issue
documents (where applicable) in relation to the issue of the Relevant Securities.



               (v) Subject to Section 4(i)(ii) above, the completion of the Investor’s subscription
of the Additional Convertible Preferred Shares or the Relevant Securities (as the case may be)
pursuant to section 4(i)(ii) above shall occur simultaneously with the completion of the issue of
Relevant Securities. For the avoidance of doubt, the completion by the Company of the issue of the
Relevant



 - 20 - 









 




Securities shall not be affected by the timing of the completion of any issue of the
Additional Convertible Preferred Shares or the Relevant Securities (as the case may be) to the
Investor. The Investor shall execute and deliver to the Company all transaction documents related
to the Investor’s subscription of the Additional Convertible Preferred Shares or the Relevant
Securities (as the case may be) as may be reasonably requested by the Company prior to the
completion of the Investor’s subscription of the Additional Convertible Preferred Shares or the
Relevant Securities (as the case may be). At such completion, the Investor shall deliver the
aggregate subscription price for the Additional Convertible Preferred Shares or the Relevant
Securities (as the case may be) to be subscribed by the Investor pursuant to Section 4(i)(ii)
above.




               (vi) The provisions of Sections 4(i)(i) to 4(i)(v) shall not apply to:




               (1) the grant of any options, or the issue of any Relevant Securities pursuant to the exercise
of share options granted (whether prior to or after the date of this Agreement), pursuant to any
share purchase or share option plans of the Company in effect from time to time;




               (2) the issue of any Relevant Securities pursuant to any share incentive scheme operated by
the Company from time to time;




               (3) the issue of any Common Shares or other securities pursuant to the conversion, exchange or
exercise of any securities that were previously offered and/or issued to the Investor (including
its Permitted Transferee, if applicable) as Relevant Securities;




               (4) any offer of the Relevant Securities open for a period fixed by the Board to holders of
Common Shares on the register of members on a fixed record date in proportion to their then
holdings of Common Shares; provided that such offer of Relevant Securities is also made to the
Investor;




               (5) an issue of Common Shares as fully paid to holders of Common Shares (including without
limitation, Common Shares paid up out of distributable profits or reserves and/or share premium
account issued in lieu of the whole or any part of any cash dividend and free distributions or
bonus issue of Common Shares); provided that such issuance of Common Shares is also made to the
Investor;




               (6) an issue of the Relevant Securities pursuant to the acquisition of another corporation by
the Company by merger, purchase of substantially all of the assets or other reorganisation or to a
joint venture agreement; provided, that such issuance is approved by the Board;




               (7) an issue of the Relevant Securities to banks, equipment lessors or other financial
institutions pursuant to a commercial leasing or commercial loan transaction approved by at least
two-thirds (2/3) of the Board (which shall, for the purposes of this Section 4(i)(vi)(7), exclude
the Investor Nominee);




               (8) an issue of Relevant Securities in connection with sponsored research, collaboration,
technology license, development, OEM, marketing or other similar agreements or strategic
partnerships approved by at least two-thirds (2/3) of the Board (which shall, for the purposes of
this Section 4(i)(vi)(8), exclude the Investor Nominee);



 - 21 - 









 






               (9) an issue of Relevant Securities to suppliers or third party service providers in
connection with the provisions of goods or services pursuant to transactions approved by at least
two-thirds (2/3) of the Board (which shall, for the purposes of this Section 4(i)(vi)(9), exclude
the Investor Nominee);




               (10) the issue of any Relevant Securities the issuance of which is specifically excluded from
the provisions of this Section 4(i) by unanimous vote or unanimous written consent of the Board .



               (vii) The rights set forth in this Section 4(i) shall not apply with respect to and
shall expire immediately prior to a transaction that would result in a change of control (as such
term is defined under the Hong Kong Takeovers Code).




“Business Day” shall mean a day that is not a Saturday, Sunday or a public holiday in Hong Kong or
the People’s Republic of China.



               (viii) The Company and the Investor acknowledge and agree that the Investor’s exercise
of the rights in this Section 4(i) shall in all cases be subject to compliance with the rules,
regulations, laws and requirements of applicable government and regulatory bodies, including the
Hong Kong Listing Rules, the Hong Kong Takeovers Code, the Stock Exchange of Hong Kong Limited and
the Securities and Futures Commission of Hong Kong (including, where applicable any requirements to
obtain the approval of the shareholders of the Company), and shall take such steps reasonably
necessary to give effect to the rights contained in this Section 4(i) in compliance with rules,
regulations, laws and requirements of applicable government and regulatory bodies, provided that
all costs and expenses (including, without limitation, reasonable legal fees and expenses) incurred
by the Company shall be resolved in a manner consistent with any terms agreed to by the Company and
the other potential investor(s) with respect to the issuance described in the relevant Issue
Notice.



          (j) Discussion.
Subject to applicable law, rules, regulations and requirements
(including the Hong Kong Listing Rules and the requirements of the SEHK and NYSE), during the
period from the date of this Agreement and continuing until the earlier of the termination of this
Agreement pursuant to Section 8(a) hereof or the Closing, the Company will use its reasonable
efforts to meet with, and/or communicate with representatives of the Investor upon reasonable
request and to discuss any material operational matters in good faith and to consider whether and
how to exercise its discretion to implement any reasonable suggestions from the Investor.



          (k) Board Nominee.



               (i) The Investor shall have the right to nominate one member of the Board (the
“Investor Nominee”); provided that




               (1) the nomination and appointment of the Investor Nominee is considered by the Board (which
shall, for the purposes of this Section 4(k), exclude the Investor Nominee) to be in the best
interest of the Company and its shareholders as a whole; and



 - 22 - 









 






               (2) the Investor Nominee shall pass the Company’s conflict and background check in accordance
with common and usual standards and policies generally applicable to the appointment and nomination
of a director of the Company.




               The Company shall use its reasonable efforts to complete all applicable internal procedures
and to give effect to the appointment of Investor Nominee as the member of the Board as soon as
practicable following the Closing, and in any event not later than 31 August 2011.




	 	5.	 	CONDITIONS TO THE COMPANY’S OBLIGATION TO ISSUE AND TO THE INVESTOR’S OBLIGATION TO
SUBSCRIBE.






          The obligation of the Company hereunder to issue the Initial Convertible Preferred Shares and
the Warrants to the Investor at the Closing and the obligation of the Investor hereunder to
subscribe for the Initial Convertible Preferred Shares and the Warrants from the Company hereunder
are each subject to the satisfaction, at or before the Closing Date, of each of the following
conditions, provided that these conditions may be waived, in whole or in part, by either party
hereto only as regards the obligations of the other party to procure the relevant conditions, at
any time in its sole discretion by providing the other party hereto with prior written notice
thereof:




	 	(a)	 	Shareholder’s approval for the issue of Initial Convertible
Preferred Shares and the Warrants. The Company having obtained the approval of
the shareholders of the Company in general meeting of a special mandate to the
issue of the Initial Convertible Preferred Shares and the Warrants issuable at
Closing pursuant to this Agreement, the Convertible Preferred Shares issuable upon
the exercise of the Warrants and the Common Shares upon conversion of the Initial
Convertible Preferred Shares and the Convertible Preferred Shares issuable upon the
exercise of the Warrants (including those Common Shares issuable as a result of any
adjustment to the Conversion Rate pursuant to the rights of the Convertible
Preferred Shares as set out in Schedule A).
	 
	 	(b)	 	SEHK Listing. Approval for the issue of the Initial
Convertible Preferred Shares and the Warrants issuable at Closing, the Convertible
Preferred Shares issuable upon the exercise of the Warrants and the listing of, and
permission to deal in, the Common Shares to be issued upon conversion of such
Convertible Preferred Shares (including those Common Shares issuable as a result of
any adjustment to the Conversion Rate pursuant to the rights of the Convertible
Preferred Shares as set out in Schedule A) shall have been duly obtained from the
SEHK and such approval not subsequently being revoked prior to Closing.
	 
	 	(c)	 	No Governmental Prohibition. The issue of the Securities by
the Company and the subscription of the Securities by the Investor shall not be
prohibited by any law or governmental order or regulation.





 - 23 - 









 






	 	6.	 	CONDITIONS TO THE COMPANY’S OBLIGATION TO ISSUE.






          The obligation of the Company hereunder to issue the Initial Convertible Preferred Shares and
the Warrants to the Investor is subject to the satisfaction, at or before the Closing Date, of each
of the following conditions, provided that these conditions are for the Company’s sole benefit and
may be waived by the Company, in whole or in part, at any time in its sole discretion by providing
the Investor with prior written notice thereof:




	 	(a)	 	Representations and Warranties; Covenants. The representations
and warranties of the Investor shall be true and correct in all material respects
as of the date of this Agreement and as of the Closing Date as though made at that
time (except for representations and warranties that speak as of a specific date,
which shall be true and correct as of such specified date), and the Investor shall
have performed, satisfied and complied in all material respects with the covenants,
agreements and conditions required by this Agreement to be performed, satisfied or
complied with by the Investor at or prior to the Closing Date.






	 	7.	 	CONDITIONS TO THE INVESTOR’S OBLIGATION TO SUBSCRIBE.






          The obligation of the Investor hereunder to subscribe for the Initial Convertible Preferred
Shares and the Warrants at the Closing is subject to the satisfaction, at or before the Closing
Date, of each of the following conditions, provided that these conditions are for the Investor’s
sole benefit and may be waived by the Investor, in whole or in part, at any time in its sole
discretion by providing the Company with prior written notice thereof:




	 	(a)	 	Completion of due diligence by Investor. The Investor shall
have completed to its reasonable satisfaction its inspection and investigation as
to the Group, including, without limitation, the financial and legal aspects of the
Group.
	 
	 	(b)	 	No occurrence of an event with Material Adverse Effect. There
shall not have occurred any event which may have any Material Adverse Effect in
respect of the Company and its subsidiaries taken as a whole.
	 
	 	(c)	 	Execution of other documents. The Company shall have duly
executed and delivered to the Investor the documents set forth in Section
1(b)(ii)(B).
	 
	 	(d)	 	Representations and Warranties; Covenants. The representations
and warranties of the Company contained in this Agreement shall be true and correct
in all material respects as of the date of this Agreement and as of the Closing
Date as though made at that time (except for representations and warranties that
speak as of a specific date, which shall be true and correct as of such specified
date), and the Company shall have performed, satisfied and complied in all material
respects with the covenants, agreements and conditions required by the Transaction
Documents to be




 - 24 - 









 






	 	 	 	performed, satisfied or complied with by the Company at or prior to the Closing
Date.






	 	8.	 	TERMINATION.






	 	(a)	 	Subject to Section 8(b) below, this Agreement may be terminated and the
transactions contemplated by this Agreement abandoned at any time prior to the
Closing:





                    (i) by mutual agreement of the Company and the Investor;



                    (ii) by the Company or the Investor if the Closing Date shall not have occurred by 31
July, 2011 or any other date as may be agreed between the parties; provided, however, that the
right to terminate this Agreement under this Section 8(a)(ii) shall not be available to a party if
such party’s action or failure to act has been a principal cause of or resulted in the failure of
the Closing to occur on or before such date and such action or failure to act constitutes breach of
this Agreement;



                    (iii) by the Company or the Investor if any legislative body, court, administrative
agency or commission or other governmental authority, instrumentality, agency or commission shall
have enacted, issued, promulgated, enforced or entered any law or governmental regulation or order
which has the effect of prohibiting the issuance of the Securities;



                    (iv) by the Investor if there has been a material breach of any representation or
warranty of the Company hereunder that would have a Material Adverse Effect on the Company or any
material breach of any covenant or agreement of the Company hereunder; and



                    (v) by the Company if there has been a material breach of any representation,
warranty, covenant or agreement of the Investor contained in this Agreement.




	 	(b)	 	In the event of termination of this Agreement as provided in Section
8(a) above, this Agreement shall forthwith become void and there shall be no
liability or obligation on the part of the parties hereto and, as applicable, the
officers, directors and shareholders of each party; provided that each
party hereto shall remain liable for any breaches of this Agreement or of any
certificate or other instruments delivered pursuant to this Agreement prior to its
termination; and provided further that the provisions of Sections 8
and 9 hereof shall remain in full force and effect and survive any termination of
this Agreement pursuant to the terms of this Section 8.






	 	9.	 	MISCELLANEOUS.






	 	(a)	 	Governing Law; Arbitration. All questions concerning the
construction, validity, enforcement and interpretation of this Agreement shall be
governed by and construed in accordance with the laws of Hong Kong. Any dispute,
controversy or claim arising out of or relating to this Agreement, or the
interpretation, breach,




 - 25 - 









 






	 	 	 	termination or validity hereof, shall be submitted to arbitration upon the request
of any party with notice to the other parties. The arbitration shall be conducted
in Hong Kong under the auspices of the Hong Kong International Arbitration Centre
(the “HKIAC”) in accordance with the UNCITRAL Arbitration Rules (“UNCITRAL Rules”)
in effect, which rules are deemed to be incorporated by reference into this Section
9(a). There shall be three (3) arbitrators. The complainant and the respondent to
such dispute shall each select one arbitrator within thirty (30) days after giving
or receiving the demand for arbitration. The Chairman of the HKIAC shall select the
third arbitrator, who shall be qualified to practice law in Hong Kong. If either
party to the arbitration does not appoint an arbitrator who has consented to
participate within thirty (30) days after selection of the first arbitrator, the
relevant appointment shall be made by the Chairman of the HKIAC. The arbitration
proceedings shall be conducted in English. Neither party shall be required to give
general discovery of documents, but may be required to produce specific, identified
documents that are relevant to the dispute. Each party irrevocably waives, to the
fullest extent it may effectively do so, any objection which it may now or hereafter
have to the laying of venue of any such arbitration in Hong Kong and the HKIAC, and
hereby submits to the exclusive jurisdiction of HKIAC in any such arbitration. The
award of the arbitration tribunal shall be conclusive and binding upon the disputing
parties, and any party to the dispute may apply to a court of competent jurisdiction
for enforcement of such award. Any party to the dispute shall be entitled to seek
preliminary injunctive relief in aid of arbitration, if possible, from any court of
competent jurisdiction pending the constitution of the arbitral tribunal.






	 	(b)	 	Effect of Completion. Without prejudice to other provisions of
this Agreement, the representation, warranty, covenant or undertaking (the
“Warranties”) contained in this Agreement shall remain in full force and effect
notwithstanding Closing except as terminated pursuant to the terms hereof or by a
waiver or release by the party entitled to enforce such Warranties.






	 	(c)	 	Remedies and waivers. No delay or omission by any party to this
Agreement in exercising any right, power or remedy provided by law or under this
Agreement or any other documents referred to in it shall: (i) affect that right,
power or remedy; or (ii) operate as a waiver thereof. The single or partial
exercise of any right, power or remedy provided by law or under this Agreement
shall not preclude any other or further exercise or any other right, power or
remedy. Except as otherwise expressly provided in this Agreement, the rights,
powers and remedies provided in this Agreement are cumulative and not exclusive of
any rights, powers and remedies provided by law.






	 	(d)	 	Counterparts. This Agreement may be executed in two or more
identical counterparts, all of which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and
delivered




 - 26 - 









 






	 	 	 	to the other party. A facsimile signature shall be considered due execution and
shall be binding upon the signatory thereto with the same force and effect as if the
signature were an original, not a facsimile signature.






	 	(e)	 	Languages. This Agreement is being executed in English only.
	 
	 	(f)	 	Headings. The headings of this Agreement are for convenience
of reference and shall not form part of, or affect the interpretation of, this
Agreement.
	 
	 	(g)	 	Severability. If any provision of this Agreement shall be
invalid or unenforceable in any jurisdiction, such invalidity or unenforceability
shall not affect the validity or enforceability of the remainder of this Agreement
in that jurisdiction or the validity or enforceability of any provision of this
Agreement in any other jurisdiction.
	 
	 	(h)	 	Confidentiality. The parties hereto acknowledge that the
Company and the Investor have previously executed a Confidentiality Agreement and
the executed Confidentiality Agreement was delivered by email by the Investor to
the Company on 17 March, 2011 (the “Confidentiality Agreement”), which
Confidentiality Agreement will continue in full force and effect in accordance with
its terms and shall survive any termination of this Agreement. The Investor shall
procure that and its Permitted Transferee shall observe the terms of the
Confidentiality Agreement.
	 
	 	(i)	 	Entire Agreement; Amendments. This Agreement, the other
Transaction Documents and the Confidentiality Agreement supersede all other prior
oral or written agreements between the Investor, the Company, their affiliates and
Persons acting on their behalf with respect to the matters discussed herein, and
this Agreement, the other Transaction Documents and the instruments referenced
herein and therein contain the entire understanding of and agreement between the
parties with respect to the matters covered herein and therein and, except as
specifically set forth herein or therein, neither the Company nor the Investor
makes any representation, warranty, covenant or undertaking with respect to such
matters. In entering into this Agreement and the other Transaction Documents, each
part to such agreements acknowledges that it is not relying upon any
pre-contractual statement which is not expressly set out in them. No provision of
this Agreement may be amended other than by an instrument in writing signed by the
Company and the Investor. No provision hereof may be waived other than by an
instrument in writing signed by the party against whom enforcement is sought.




Without prejudice to Section 3A(o) above pursuant to which the Company represents and
warrants that all information given in connection with the transactions contemplated by this
Agreement by the Company or on its behalf by the Company’s advisers, to the Investor or the
Investor’s advisers, relating to the Company,






 - 27 - 









 







its subsidiaries or their respective business, activities, affairs, or assets or liabilities
(including all documents attached thereto) was, when given, and is now accurate in all material
respects and not misleading in any material respect, and there is no material omission that would
render the information given misleading in any material respect, except in the case of fraud, no
party shall have any right of action against any other party to this Agreement or the other
Transaction Documents arising out of or in connection with any pre-contractual statement except to
the extent that it is repeated in this Agreement and/or the other Transaction Documents.



For the purposes of this section, “pre-contractual statement” means any draft, agreement,
undertaking, representation, warranty, promise, assurance or arrangement of any nature whatsoever,
whether or not in writing, relating to the matters covered in this Agreement and/or the other
Transaction Documents made or given by any person at any time prior to the date of this Agreement
or the other Transaction Documents.





	 	(j)	 	Notices. Any notices, consents, waivers or other
communications required or permitted to be given under the terms of this Agreement
must be in writing and will be deemed to have been delivered: (i) upon receipt,
when delivered personally; (ii) upon receipt, when sent by facsimile (provided
confirmation of transmission is mechanically or electronically generated and kept
on file by the sending party); or (iii) one Business Day after deposit with an
overnight courier service, in each case properly addressed to the party to receive
the same. The addresses and facsimile numbers for such communications shall be:





	 	 	 	 	 

	If to the Company:	 	 
	 
	 	 	 	 
	 	 	Semiconductor Manufacturing International Corporation
	 

	 	Address:
	 	18, Zhangjiang Road
	 

	 	 	 	Pudong New Area, Shanghai
	 

	 	 	 	People’s Republic of China
	 

	 	Telephone:
	 	(86-21) 3861-0000
	 

	 	Facsimile:
	 	(86-21) 5080 4000
	 

	 	Attention:
	 	Barry Quan/Chief Administration Officer
	 
	 	 	 	 
	with a copy to:	 	 
	 
	 	 	 	 
	 	 	Semiconductor Manufacturing International Corporation
	 

	 	Address:
	 	Suite 3003, 30th Floor
	 

	 	 	 	No. 9 Queen’s Road Central
	 

	 	 	 	Hong Kong
	 

	 	Telephone:
	 	(852) 2537-8588
	 

	 	Facsimile:
	 	(852) 2537 8206
	 

	 	Attention:
	 	Anne Chen/Blondie Poon
	 
	If to the Investor:	 	 






 - 28 - 









 






	 	 	 	 	 

	 	 	Country Hill Limited
	 

	 	Address:
	 	Room 2501, New Poly Plaza
	 

	 	 	 	No. 1 Chaoyangmen Beidajie
	 

	 	 	 	Dongcheng District
	 

	 	 	 	Beijing 100010
	 

	 	 	 	People’s Republic of China
	 

	 	Telephone:
	 	Bai Xiaoqing: tel: (86-10) 8409-6969
	 

	 	 	 	Li Tao: tel: (86-10) 8409-6741
	 

	 	 	 	Li Yang: tel: (86-10) 8409-6743
	 

	 	Facsimile:
	 	(86-10) 6408-6710
	 

	 	Attention:
	 	Bai Xiaoqing/Li Tao/Li Yang







	 	(k)	 	Successors and Assigns. This Agreement shall be binding upon
and inure to the benefit of the parties and their respective successors and
assigns. Neither party hereto shall not assign this Agreement or any rights or
obligations hereunder without the prior written consent of the other party hereto.
	 
	 	(l)	 	No Third Party Beneficiaries. This Agreement is intended for
the benefit of the parties hereto and their respective permitted successors and
assigns, and is not for the benefit of, nor may any provision hereof be enforced
by, any other Person.
	 
	 	(m)	 	Non-Survival. Unless this Agreement is terminated under
Section 8, the representations and warranties of the Company and the Investor in
Sections 2 and 3, or in any instrument delivered pursuant to this Agreement, shall
survive the Closing until the expiration of the applicable statute of limitations,
it being understood that no claim may be brought for a breach of representations or
warranties following such time. Only the agreements and covenants set forth in
Section 4(b), (c), (e), (f), (h), (i), (j) and (k) survive the Closing and this
Section 9 shall survive the Closing.
	 
	 	(n)	 	Further Assurances. Each party shall do and perform, or cause
to be done and performed, all such further acts and things, and shall execute and
deliver all such other agreements, certificates, instruments and documents, as any
other party may reasonably request in order to carry out the intent and accomplish
the purposes of this Agreement and the consummation of the transactions
contemplated hereby.





[Signature Page Follows]




 - 29 - 









 





     IN WITNESS WHEREOF, the Investor and the Company have caused its respective signature page to
this Share Subscription Agreement to be duly executed as of the date first written above.



	 	 	 	 	 
	 	COMPANY:



Semiconductor Manufacturing International Corporation

 	 
	 	By:  	 	 
	 	 	Name:  	Jiang Shang Zhou 	 
	 	 	Title:  	Chairman of the Board 	 
	 



SIGNATURE PAGE TO THE SUBSCRIPTION AGREEMENT





 









 





     IN WITNESS WHEREOF, the Investor and the Company have caused their respective signature page
to this Share Subscription Agreement to be duly executed as of the date first written above.



	 	 	 	 	 
	 	INVESTOR:



Country Hill Limited

 	 
	 	By:  	 	 
	 	 	Name:  	Gao Xiqing 	 
	 	 	Title:  	Executive Director and President 	 
	 



SIGNATURE PAGE TO THE SUBSCRIPTION AGREEMENT





 









 





SCHEDULES




	 	 	 

	Schedule A

	 	Rights attaching to the Convertible Preferred Shares
	Schedule B

	 	Form of Secretary’s Certificate
	Schedule C

	 	Form of the Warrant Agreement






 - 32 - 









 





SCHEDULE A




RIGHTS ATTACHING TO THE CONVERTIBLE PREFERRED SHARES



 - 33 - 









 





SCHEDULE B




SECRETARY’S CERTIFICATE

[insert date]


Pursuant to Section 1(b)(ii)(B)(5) of the Share Subscription Agreement (the “Agreement”), dated as
of 18 April, 2011, between Semiconductor Manufacturing International Corporation, a
Cayman Islands company (the “Company”), and Country Hill Limited, the undersigned
certifies on behalf of the Company as follows:




     1. The undersigned is the Secretary of the Company.



     2. Attached as Exhibit A is a true and complete copy of the resolutions duly adopted by the
board of directors of the Company authorising the transactions contemplated by the Agreement. The
resolutions (i) were adopted in compliance with the memorandum and association and articles of
association of the Company, (ii) have not been amended, modified or rescinded since their adoption
and (iii) are in full force and effect as of the date hereof.



     3. Attached as Exhibit B is a true and complete copy of the memorandum and association and
articles of association of the Company as in effect on the date hereof (the “Articles”). No steps
have been taken by the board of directors or shareholders of the Company to authorise or effect any
amendment or other modification to the Articles, other than as may be contemplated by the
Agreement.



(signature page follows)






 - 34 - 









 







The undersigned signs this certificate in [his/her] capacity as Secretary of the Company as of the
date first set forth above.




	 	 	 	 	 

	 	 	Semiconductor Manufacturing International
	 	 	Corporation
	 	 	a Cayman Islands company
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	Title:
	 	Secretary






 - 35 - 









 





SCHEDULE C




Form of the Warrant Agreement



 - 36 - 









 





18 April, 2011




Semiconductor Manufacturing International Corporation



and



Country Hill Limited



 





SHARE SUBSCRIPTION AGREEMENT



relating to

the subscription of convertible preferred

shares and warrants over convertible

preferred shares of Semiconductor

Manufacturing International Corporation



 





Slaughter and May

47th Floor, Jardine House

One Connaught Place

Central

Hong Kong

(BKPY/JHXC)

(HK110910052_49.doc)




  











 





Rights of the Convertible Preferred Shares



The rights and restrictions to be attached to the convertible preferred shares of par value
US$0.0004 each of Semiconductor Manufacturing International Corporation (the “Company”) (the
“Convertible Preferred Shares”) are set out below.





	1.	 	Ranking and dividend entitlements
	 
	 	 	The Convertible Preferred Shares shall rank pari passu with the claims of holders of (i)
any class of preferred share capital of the Company and (ii) any other obligations of the
Company which rank pari passu with the Convertible Preferred Shares.
	 
	 	 	The Convertible Preferred Shares shall rank pari passu in respect of entitlement to
dividends and other income distribution as ordinary shares of the Company (“Common Shares”)
as if the Convertible Preferred Shares had been converted into Common Shares pursuant to
the terms hereof for the relevant accounting period.
	 
	2.	 	Capital
	 
	2.1	 	On a liquidation, dissolution, winding up (whether voluntary or involuntary) or return or
reduction of capital of the Company (but not on conversion of the Convertible Preferred Shares
or any repurchases by the Company of any Convertible Preferred Shares or Common Shares) the
assets of the Company available for distribution among the members shall be applied first in
paying to the holders of the Convertible Preferred Shares and holders of other preference
shares of the Company an amount in repayment of capital equal to the amount paid up or
credited as paid up on such shares in priority to:






	 	(A)	 	any payment to the holders of Common Shares; and
	 
	 	(B)	 	any other obligations ranking pari passu with the claims of the holders of
Common Shares.






	2.2	 	For the purpose of determining the value of any distribution pursuant to this paragraph 2,
the value of any asset or property distributed shall be computed at fair market value at the
time of the distribution as determined by the board of directors of the Company in the good
faith exercise of its reasonable business judgment.
	 
	3.	 	Conversion
	 
	3.1	 	Conversion right
	 
	 	 	The holders of the Convertible Preferred Shares shall have the right exercisable, subject
as provided in paragraph 3.3 below, at any time to convert (in whole or in part) their
Convertible Preferred Shares into fully paid Common Shares at the Conversion Rate (as
defined below). The holders of the Convertible Preferred Shares are not required to pay
any amount for conversion of their Convertible Preferred Shares into Common Shares. The
Common Shares issued upon conversion shall be credited as fully paid, shall rank pari passu
in all respects with the other Common Shares in issue




 









 





2


	 	 	as at the date of the conversion, and shall be allotted and issued free from all liens,
charges and encumbrances and together with all rights attaching thereto upon allotment and
issue and at any time thereafter, including all rights to any dividend or other
distribution declared, made or payable by reference to a record date falling on or after
the date on which the Convertible Preferred Shares are converted into Common Shares in
accordance with paragraph 3.3 below).






	 	 	“Conversion Rate” means the number of Common Share(s) into which each Convertible Preferred
Share is converted upon conversion, which initially is ten Common Share per Convertible
Preferred Share (subject to adjustment(s) as provided in the other provisions of this
paragraph 3).
	 
	3.2	 	Conversion
	 
	 	 	The Convertible Preferred Shares shall be mandatorily converted into Common Shares at the
then applicable Conversion Rate on the day immediately following the expiry of twelve
months commencing from the closing date of the Subscription Agreement (the “Mandatory
Conversion Date”) as if the holder of the Convertible Preferred Shares has elected to
convert its Convertible Preferred Shares into Common Shares on the Mandatory Conversion
Date. The holder of Convertible Preferred Shares shall deliver to the Company
certificate(s) evidencing its holding of Convertible Preferred Shares on the Mandatory
Conversion Date.
	 
	 	 	For the avoidance of doubt, any holder of Convertible Preferred Share(s) may, at any time
on or before the Mandatory Conversion Date, elect solely at its option to convert its
Convertible Preferred Shares (in whole or in part) outstanding into Common Shares at the
then applicable Conversion Rate.
	 
	3.3	 	Exercise






	 	(A)	 	Any holder of the Convertible Preferred Shares which wishes to convert its
Convertible Preferred Shares pursuant to paragraph 3.1 above shall deliver to the
Company at its principal place of business in Hong Kong a written notice (the
“Conversion Notice”) that it elects to convert such number of Convertible Preferred
Shares as specified in the Conversion Notice (which shall be for a minimum amount of
70,000,000 Convertible Preferred Shares or, if less than 70,000,000 Convertible
Preferred Shares are then held by the Investor, all of such Convertible Preferred
Shares) together with the certificate(s) evidencing the Convertible Preferred Shares
to be converted.
	 
	 	(B)	 	The Company shall, not later than 10 Business Days after the date of receipt
of the Conversion Notice (or, as the case may be, the Mandatory Conversion Date):






	 	(i)	 	either:






	 	(a)	 	issue and deliver to the relevant holder of
the Convertible Preferred Shares or its nominee(s) certificate(s) for
the number




 









 




3


	 	 	 	of Common Shares into which the Convertible Preferred Shares are
converted in the name as shown on the certificate(s) evidencing
the Convertible Preferred Shares so surrendered to the Company; or






	 	(b)	 	at the request of the relevant holder of the
Convertible Preferred Shares, cause to be credited into its or its
nominee’s brokers’ account, details of which will be set out in the
Conversion Notice, such number of Common Shares into which the
Convertible Preferred Shares are converted; and






	 	(ii)	 	enter such holder of Convertible Preferred Shares (or its
nominee(s)) in its register of shareholders in respect of the relevant number
of Common Shares arising from such conversion, and the Convertible Preferred
Shares which have been converted into Common Shares shall be treated as
cancelled.






	 	 	 	“Business Day” in this document shall mean a day that is not a Saturday, Sunday or
a public holiday in Hong Kong or the People’s Republic of China.
	 
	 	(C)	 	The Company shall be responsible for, and shall pay directly to the relevant
authorities, all taxes (if any), costs and expenses payable on its part and for its
own account arising from any conversion.






	3.4	 	Fractional Shares
	 
	 	 	No fraction of a Common Share shall be issued upon the conversion of Convertible Preferred
Shares. If the number of Common Shares as calculated by reference to the applicable
Conversion Rate would carry a fractional number of a Common Share, it will be rounded
downwards to the nearest whole number. For the avoidance of doubt, such rounding applies
only to the calculation of the number of Common Shares issuable upon each conversion, after
the applicable Conversion Rate is determined in accordance with the other provisions of
this paragraph 3. Such fractional entitlement shall be deemed to have been waived by the
holder of the Convertible Preferred Shares and any sum paid in respect of such subscription
shall be retained by the Company for its own benefit.
	 
	3.5	 	Methods of Conversion
	 
	 	 	Conversion of the Convertible Preference Shares may be effected in such manner as the law
may allow.
	 
	3.6	 	Adjustments
	 
	 	 	Without prejudice to paragraph 3.6(E) below, from the date of this Agreement, if any
Convertible Preference Shares are issued and whilst any of them remains capable of being
converted into Common Shares:





 









 




4


	 	(A)	 	Capitalisation issues, consolidations, sub-divisions and re-classifications
	 
	 	 	 	Upon any allotment of fully paid Common Shares pursuant to a
capitalisation of profits or reserves to any holders of Common Shares, any
consolidation into a smaller number of issued Common Shares, any sub-division
into a greater number of issued Common Shares or any re-classification or
other corporate exercise whereby the Commons Shares become of a different
nominal amount, the Conversion Rate shall be adjusted (rounded upwards to the
nearest 0.0001) so that the number of Common Shares to be issued in respect of
the Convertible Preferred Shares converted on any date on or following the
record date for such allotment, consolidation, sub-division, re-classification
or the relevant corporate exercise shall be the number which the converting
holder of the Convertible Preferred Shares would have been entitled after such
event had its Convertible Preferred Shares been converted immediately prior to
the relevant record date. Each such adjustment shall become effective, in the
case of a capitalisation issue, from the commencement of the day next
following the date of such capitalisation issue, and in any other case, from
the day immediately after the date on which the relevant corporate exercise
becomes effective.
	 
	 	(B)	 	Capital distributions
	 
	 	 	 	Upon any capital distribution by the Company to holders of Common
Shares, whether on a reduction or redemption of capital or otherwise, or any
grant by the Company to holders of Common Shares any right to acquire cash
asset(s) of the Company or of any of its subsidiaries, in each case only if
(i) the distribution or right is not made or granted to the holder of the
Convertible Preferred Shares and (ii) paragraph 3.6(C) and paragraph 3.6(D)
does not apply , the Conversion Rate in force immediately before such capital
distribution or grant shall be adjusted (rounded upwards to the nearest
0.0001) by multiplying it by the following ratio/fraction:
	 
	 	 	 	     X      
	 
	 	 	 	  X – Y
	 
	 	 	 	where:






	 	X      =    	 	the Prevailing Market Price (as defined below) applicable
to the date on which the capital distribution or the grant of right, as the
case may be, is publicly announced or (where no such announcement is required
to be made under the Rules Governing the Listing of Securities on The Stock
Exchange of Hong Kong Limited (the “Hong Kong Listing Rules”)) the date next
preceding the record date of the capital distribution or the grant, as the
case may be; and
	 
	 	Y      =   	 	 the fair market value on the day of the announcement or
(where no such announcement is required to be made under the Hong Kong




 









 





5

	 	 	 	 Listing Rules) the date next preceding the date of the
capital distribution or the grant, as the case may be, as
determined in good faith by the auditors of the Company, of the
portion of such capital distribution or such right to the grant,
as the case may be, which is attributable to one Common Share,






	 	 	 	provided that:






	 	(i)	 	if 75% of the holders of the Convertible Preferred Shares
disagrees with the calculation by the Company of Y above, such holders shall
have the right to appoint an independent financial adviser acting as an expert
(and not as an arbitrator), at the cost of the holders of the Convertible
Preferred Shares, for the purpose of calculating Y above; and
	 
	 	(ii)	 	the provisions of this sub-paragraph shall not apply in
relation to any issue of Common Shares paid out of profits or reserves and
issued in lieu of a cash dividend, nor to any purchase by the Company of its
own Common Shares in accordance with applicable laws, regulations and rules;
and






	 	 	 	“Capital distribution” includes, without prejudice to the generality of that
expression, distributions in cash or specie. Any dividend charged or provided for
in the accounts for any financial period, whenever paid and however described, is
considered a capital distribution;
	 
	 	 	 	“Prevailing Market Price” means in respect of the Common Shares on a
particular date, the average closing price for a Common Share as shown on the Daily
Quotations List of The Stock Exchange of Hong Kong for the five consecutive Trading
Days immediately before (and excluding) that date;
	 
	 	 	 	“Trading Day” means a day on which Common Shares are traded on The Stock
Exchange of Hong Kong Limited,
	 
	 	 	 	with each such adjustment becoming effective from the commencement of the day
next following the date of the capital distribution or the grant, as the case may
be.
	 
	 	(C)	 	Issues of shares or other securities
	 
	 	 	 	Upon any issue by the Company of any Common Share, or any issue of any securities,
which by their terms are convertible into or exchangeable for, or carry right(s) of
subscription for, any Common Share, the Conversion Rate in force immediately before
such issue shall be adjusted (rounded upwards to the nearest 0.0001) by multiplying
it by the following ratio/fraction:





 









 




 6


     Reference Price per Common Share     




     Adjusted Price per Common Share




	 	 	 	where:
	 
	 	 	 	“Reference Price per Common Share” is






	 	(i)	 	HK$0.5390, representing a discount of 10% to the arithmetic
average of the daily volume weighted average price for a Common Share as shown
on the VAP page of Bloomberg for the 5 consecutive Trading Days immediately
before (and excluding) 18 April 2011, rounded downwards to the nearest
HK$0.0001 (the “Initial Reference Price”); or
	 
	 	(ii)	 	If the Conversion Rate had been adjusted in accordance with
this paragraph 3.6 prior to the issue of securities giving rise to the
adjustment hereunder, the latest conversion price arrived at by dividing the
Initial Reference Price by the prevailing Conversion Rate immediately before
the issue of securities giving rise to the adjustment hereunder; and






	 	 	 	“Adjusted Price per Common Share” is the amount which is the lowest of:






	 	(i)	 	the Reference Price per Common Share;
	 
	 	(ii)	 	the amount which represents:






	 	(a)	 	in respect of any rights issue of Common
Shares by the Company, 90% of the relevant theoretical ex-rights
price for a Common Share under that rights issue;
	 
	 	(b)	 	in respect of any issue of securities which
by their terms are convertible into or exchangeable for, or carry
right(s) of subscription for, Common Share(s):






	 	(1)	 	in the case of options,
warrants or similar instruments, the aggregate of the
subscription price or premium for such instrument and the
initial exercise price at which the holder of such instrument
may subscribe for Common Shares;
	 
	 	(2)	 	in the case of convertible
bonds or convertible shares or similar instruments, the
initial conversion price at which such instrument may be
converted into Common Shares; or




 









 




7








	 	(3)	 	in any other case, the
aggregate price paid and initially payable by the subscriber
of such securities in order to receive Common Shares;






	 	(c)	 	in respect of any other issue of Common
Shares by the Company, the relevant issue price for a Common Share
under that issue; and






	 	(iii)	 	the amount which represents a discount of 10% to the
arithmetic average of the daily volume weighted average price for a Common
Share as shown on the VAP page of Bloomberg for the:






	 	(a)	 	ten consecutive Trading Days immediately
after the date on which the relevant issue is announced;
	 
	 	(b)	 	in the case of a rights issue, ten
consecutive Trading Days immediately after the ex-rights date; or
	 
	 	(c)	 	if the reference price to determine the issue
price is based on share prices for a period after the relevant issue
is announced, all the Trading Days during that period,






	 	 	 	with each such adjustment becoming effective from commencement of the day
immediately following the date of such issuance.
	 
	 	 	 	For the avoidance of doubt, no adjustment to the Conversion Rate shall be made if
the securities issued are not Common Shares and not convertible into Common Shares.
	 
	 	(D)	 	New class of shares carrying voting rights
	 
	 	 	 	Upon the issue of any new class of shares which is not Common Shares and is not
convertible into Common Shares, but which carries any right to vote in general
meetings of shareholders of the Company (“Extraordinary Shares”), or any issue of
any securities, which by their terms are convertible into or exchangeable for, or
carry right(s) of subscription for, any Extraordinary Share, the Conversion Rate
shall be adjusted by multiplying the Conversion Rate in force immediately before
the issue by the following fraction:
	 
	 	 	 	   Y + Z   
	 
	 	 	 	     Y
	 
	 	 	 	where:






	 	Y    =   	 	 the aggregate number of voting rights in the Company
immediately prior to the relevant issuance of Extraordinary Shares




 









 





8

	 	Z    =   	 	 the aggregate number of voting rights attaching to the
relevant issuance on a fully diluted and as converted basis





	 	 	 	Each such adjustment shall become effective from commencement of the day
immediately following the date of the issuance of the Extraordinary Shares.






	 	(E)	 	If any of the events referred to in sub-paragraphs (A) to (D) above is agreed
to be made or is announced, or otherwise takes place, during the period from (and
including) the Business Day immediately before the date of this Agreement to the
Closing Date, the provisions of those sub-paragraphs (A) to (D) above shall apply
mutandis mutatis, and the Conversion Rate shall accordingly be adjusted such that the
adjustment will take effect from: (i) the effective date as provided for under such
relevant sub-paragraph (A), (B) (C) or (D) above; or (ii) the Closing Date, whichever
is later. Similarly, if any of the events referred to in sub-paragraphs (A) to (D)
above is agreed to be made or is announced, albeit not completed, by the Mandatory
Conversion Date, which subsequently completes or becomes effective following the
Mandatory Conversion Date, the provisions of those sub-paragraphs (A) to (D) above
shall likewise apply mutatis mutandis, and the Conversion Rate shall accordingly be
adjusted after the Mandatory Conversion Date on the day following the completion of
the above event or its becoming effective, such that the adjustment will take effect
from the day immediately before the Mandatory Conversion Date as if such relevant
event were completed on such date (pursuant to which the Company shall issue to the
holder of the Convertible Preferred Shares such additional Common Shares arising as a
result of the said adjustment within 10 Business Days after such adjustment),
provided that this adjustment shall not apply to the case where, after such
conversion, the holder of the Convertible Preferred Shares converted is able to
participate or benefit from the event as a holder of Common Shares.
	 
	 	(F)	 	The provisions of this paragraph 3.6 shall not apply to:






	 	(i)	 	an issue of fully paid Common Shares upon the exercise of any
subscription or conversion rights attached to securities carrying rights to
subscribe for or convertible into Common Shares that exist before the date of
this Agreement (including but not limited to the warrants issued to Taiwan
Semiconductor Manufacturing Corporation); and
	 
	 	(ii)	 	an issue of fully paid Common Shares or other securities
convertible into Common Shares to the directors or employees of the Company or
other eligible persons pursuant to an employee share option scheme or share
incentivisation scheme adopted by the Company in accordance and in compliance
with the Hong Kong Listing Rules.






	 	(G)	 	Despite any other provisions of this paragraph 3, no adjustment to the
Conversion Rate shall be made which has the effect or result of: (i) reducing the
initial Conversion Rate upon the issue of the Convertible Preference Shares, except
upon any consolidation of Common Shares or any corporate exercise




 









 





9

	 	 	 	with the effect of increasing the nominal value of the Common Shares as mentioned
under sub-paragraph (A) above; or (ii) any Common Share, upon conversion, falling
to be issued at a price below the nominal value of the Common Share.






	 	(H)	 	The Company shall immediately upon determination of any adjustment hereunder
give notice to the holders of the Convertible Preferred Shares that the Conversion
Rate has been adjusted (setting forth the Conversion Rate immediately before the
adjustment, the adjusted Conversion Rate and the event giving rise to the adjustment).
	 
	 	(I)	 	Every adjustment to the Conversion Rate shall be certified in writing by any
officer of the Company.






	4.	 	Voting
	 
	 	 	The Convertible Preferred Shares shall entitle the holders thereof to receive notice of,
attend and vote at any meeting of members of the Company. Each Convertible Preferred Share
shall confer on its holder such number of voting rights as if the Convertible Preferred
Share had been converted into Common Shares.
	 
	5.	 	Consent of Convertible Preferred Shareholders
	 
	 	 	Except with the consent or sanction of at least 75 percent of the vote of the holders of
the Convertible Preferred Shares given at a separate class meeting no resolution may be
made by the Company to amend the rights of the Convertible Preferred Shares contained
herein.
	 
	6.	 	Payments






	 	(A)	 	Payment by the Company to any holder of Convertible Preferred Share(s) of all
amounts in respect of the Convertible Preferred Shares under paragraph 1 or paragraph
2 hereof shall be made on the due dates into such bank account as the holder of the
relevant Convertible Preferred Shares may notify the Company by at least 7 Business
Days’ prior written notice from time to time. All payments made by the Company in
respect of the Convertible Preferred Shares shall be made in Hong Kong dollars in
immediately available funds.
	 
	 	(B)	 	If the due date for payment of any amount in respect of the Convertible
Preferred Shares is not a Business Day, such amount shall be paid on the following
Business Day.






	7.	 	Documents
	 
	 	 	The Company shall send to the holders of the Convertible Preferred Shares a copy of every
document sent to the holders of its Common Shares at the same time as it is sent to the
holder of the Common Shares.




 









 





10







	8.	 	Transfer
	 
	 	 	The Convertible Preferred Shares shall be freely transferrable save as provided for under
the terms of the subscription agreement between Country Hill Limited and the Company dated
18 April, 2011.
	 
	9.	 	Redemption
	 
	 	 	The Convertible Preferred Shares are non-redeemable at the call of the Company or at the
option of the holder.
	 
	10.	 	Protection of the Convertible Preferred Shareholders
	 
	10.1	 	The Company agrees with and undertakes to each holder of Convertible Preferred Share(s) that,
so long as any Convertible Preferred Share is outstanding:






	 	(A)	 	the Company shall ensure that all Common Shares issued upon any conversion
will be duly and validly allotted and issued, fully paid or credited as fully paid,
and free from all liens, charges and encumbrances;
	 
	 	(B)	 	the Company shall not in any way vary the rights attached to any class or
series of shares, or attach any restriction to any class or series of shares, to the
extent that such variation would have the effect of varying the rights attaching to
the Convertible Preferred Shares, unless with prior written approval of 75% of the
holders of Convertible Preferred Shares;
	 
	 	(C)	 	the Company shall procure that at no time shall there be in issue shares of
different nominal values;
	 
	 	(D)	 	the Company shall not without prior written approval of 75% of the holders of
Convertible Preferred Shares take any step to or so as to liquidate, dissolve or wind
up the Company or any of its subsidiaries unless such liquidation, dissolution or
winding up would not have a Material Adverse Effect.






	10.2	 	The Company shall not make any reduction or redemption of capital, share premium account or
capital redemption reserve involving repayment of money to its shareholders or reduce any
uncalled liability in respect of any issued share unless in any such case: (i) it gives rise,
or would but for the provisions of paragraph 3.6 give rise, to an adjustment of the Conversion
Rate in accordance with that paragraph 3.6; (ii) the holder of the Convertible Preferred
Shares is entitled to receive any benefit of such repayment or reduction of liability; or
(iii) with prior written approval of 75% of the holders of Convertible Preferred Shares.
	 
	10.3	 	The Company shall not enter into any agreement, instrument or other document whatsoever
binding on it which may result in any breach of the memorandum and articles of association of
the Company.






 











 





WARRANT AGREEMENT




     This WARRANT AGREEMENT, dated as of      , 2011 (the “Agreement”), is made by and between Country
Hill Limited, an exempted company incorporated in the Cayman Islands with Limited Liability with
its registered address at Walkers Corporate Services Limited, Walkers House, 87 Mary Street, George
Town, Grand Cayman KY1-9005, Cayman Islands (the “Initial Holder”), and Semiconductor Manufacturing
International Corporation, an exempted company incorporated under the laws of the Cayman Islands
having a place of business located at No. 18 Zhang Jiang Road, Pudong New Area, Shanghai 201203,
People’s Republic of China (the “Company”).



W I T N E S S E T H




     WHEREAS, the Holder and the Company entered into a subscription agreement, dated 18 April 2011
(the “Subscription Agreement”); and



     WHEREAS, pursuant to the Subscription Agreement, the Company proposes to issue 72,117,810
warrants (each a “Warrant” and collectively, the “Warrants”) to subscribe for 72,117,810 validly
issued and fully paid Convertible Preferred Shares (as defined in the Subscription Agreement, with
the Convertible Preferred Shares deliverable upon exercise of the Warrants being referred to herein
as the “Warrant Preferred Shares”).



     NOW, THEREFORE, in consideration of the mutual promises, agreements and covenants contained
herein, and for other valuable consideration, receipt of which is hereby acknowledged, the Company
and the Holder hereby agree as follows:



ARTICLE I

DEFINITIONS



1.1 Definitions.




     (a) Capitalised terms used herein and not otherwise defined shall have the meanings
set forth in the Subscription Agreement.



     (b) The following terms shall have the meanings set forth below.



     “Affiliate” means “affiliate” within the meaning of Rule 144(a)(1) under the Securities Act.



     “Agreement” shall mean this Warrant Agreement, together with all annexes attached hereto, as
amended, restated, supplemented or otherwise modified from time to time in accordance with the
terms hereof.



     “Applicable Law” means any statute, rule, regulation, law or ordinance, or any judgment,
decree or order.



1









 





     “Assignment Form” means the assignment form attached as Annex B to a Warrant.



     “Board” means the board of directors of the Company.



     “Business Day” means any day that is not a Saturday or Sunday or a day on which banks are
required or permitted to be closed in the Beijing, State of New York or Hong Kong.



     “Closing Date” has the meaning given to such term in Section 4.2(a).



     “Delivery Date” has the meaning given to such term in Section 4.2(a).



     “Exercise Form” means the exercise form attached as Annex A to a Warrant.



     “Exercise Price” means HK$5.3900 per Warrant Preferred Share.



     “Expiration Time” means 11:59 p.m., Hong Kong Time, on the date falling 12 months after the
date of the issuance of the Warrants. If such day is not a Business Day, the Expiration Time shall
be extended until 11:59 p.m., Hong Kong Time on the next Business Day.



     “Holder” means with respect to any Warrant, the holder of such Warrant as set forth in the
Warrant Register, which as of the date hereof is the Holder.



     “Initial Holder” has the meaning set forth in the preamble.



     “Person” means an individual, sole proprietorship, partnership, limited liability company,
joint venture, trust, incorporated organisation, association, corporation, institution, public
benefit corporation, entity or government (whether federal, state, county, city, municipal or
otherwise, including any instrumentality, division, agency, body or department thereof).



     “Responsible Officer” means the Chief Executive Officer, the President, the Chief Financial
Officer or any executive officer of such Person.



     “Securities Act” means the Securities Act of 1933, as amended, of the United States, or any
similar United States federal statute, and the rules and regulations of the United States
Securities and Exchange Commission thereunder, all as the same shall be in effect at the time.



     “Subscription Agreement” has the meaning given to such term in the preamble.



     “Transfer” means any sale, transfer, assignment, or other disposition of any interest in, with
or without consideration, any security, including any disposition of any security or of any
interest therein which would constitute a sale thereof within the meaning of the Securities Act.



     “Warrant” has the meaning set forth in the preamble.



2









 





     “Warrant Register” has the meaning given to such term in Section 3.1(b).



     “Warrant Preferred Shares” means the Convertible Preferred Shares deliverable upon the
exercise of the Warrants.


1.2 Rules of Construction.




     The definitions in Section 1.1 shall apply equally to the singular and plural forms of
the terms defined. The words “include”, “includes” and “including” shall be deemed to be followed
by the phrase “without limitation”. The words “herein,” “hereof,” “hereunder” and other words of
similar import refer to this Agreement as a whole, including the annexes hereto, as the same may
from time to time be amended, restated, supplemented or otherwise modified, and not to any
particular section, subsection, paragraph, subparagraph or clause contained in this Agreement. All
references to sections, schedules and exhibits mean the sections of this Agreement and the
schedules and exhibits attached to this Agreement, except where otherwise stated. The title of and
the section and paragraph headings in this Agreement are for convenience of reference only and
shall not govern or affect the interpretation of any of the terms or provisions of this Agreement.
The use herein of the masculine, feminine or neuter forms shall also denote the other forms, as in
each case the context may require. Where specific language is used to clarify by example a general
statement contained herein, such specific language shall not be deemed to modify, limit or restrict
in any manner the construction of the general statement to which it relates. Any reference to any
term contained in any other agreement or other document shall be deemed to be a reference to such
term in the applicable agreement or document as in effect as of the date hereof. The language used
in this Agreement has been chosen by the parties to express their mutual intent, and no rule of
strict construction shall be applied against any party. “HK$” shall mean Hong Kong dollars and
“US$” shall mean United States dollars.



ARTICLE II

ISSUANCE OF WARRANTS



2.1 Issuance of Warrants to Holder; Warrant Agreement.




     The Company shall issue and deliver Warrants, dated as of the date hereof, to the Holder in
accordance with this Agreement and the Subscription Agreement on the closing date under the
Subscription Agreement. The provisions of this Agreement shall apply to all Warrants (and, to the
extent applicable, Warrant Preferred Shares), and each Holder that is not a party to this
Agreement, by its acceptance of a Warrant or a Warrant Preferred Share, agrees to be bound by the
applicable provisions hereof.


2.2 Compliance with Warrants Terms.




     The parties shall comply with, in all respects, the provisions of the Warrant and the terms
and conditions contained in the Warrant Agreement and the Subscription Agreement which shall be
binding upon the Company and the Holder. Without prejudice to the generality of the foregoing, the
Company shall upon exercise (in whole or in part) of the Warrants from



3









 




time to time on or before the Expiration Time allot and issue the Warrant Preferred Shares in
accordance with the terms and conditions of this Agreement and the Subscription Agreement.




ARTICLE III

CERTAIN ADMINISTRATIVE PROVISIONS



3.1 Form of Warrant; Register.




     (a) Each Warrant issued hereunder shall be in the form of Exhibit A attached hereto
(each, a “Warrant”) and shall be executed on behalf of the Company by a Responsible Officer of the
Company. Each Warrant shall bear the legend(s) appearing on the first page of such form, except
that the Company shall promptly remove any such legend from a Warrant from and after such time as
all the restrictions to which such legend relates no longer apply.



     (b) Each Warrant issued or transferred hereunder shall be registered in a warrant register
(the “Warrant Register”) maintained at the principal office of the Company (or any other location
as the Company considers appropriate), in which register the Company shall record the name and
address of the Person in whose name this Warrant has been issued, as well as the name and address
of each successor and prior owner of such Warrant. The Warrant Register shall set forth (i) the
number of each Warrant, (ii) the name and address of the Holder thereof, (iii) the original number
of Warrant Preferred Shares which may be subscribed upon the exercise thereof, (iv) the number of
Warrant Preferred Shares which may be subscribed upon the exercise thereof, and (v) the Exercise
Price for each Warrant Preferred Share. The Warrant Register will be maintained by the
Company and will be available for inspection by any Holder at the principal office of the Company
or such other location as the Company may designate to the Holders in the manner set forth in
Section 7.1. The Company shall be entitled to treat the Holder of any Warrant as the owner in fact
thereof for all purposes and shall not be bound to recognise any equitable or other claim to or
interest in such Warrant on the part of any other Person.


3.2 Transfer of Warrants.




     (a) Save for any transfer to any Permitted Transferee (as defined in the Subscription
Agreement), the Warrants are not transferable without the prior written approval of the Company
which shall have sole and absolute discretion thereon. In the case of the Permitted Transferee,
the Warrant may be transferred, in whole or in part, by the Holder by delivering to the Company
such Warrants accompanied by a properly completed, duly executed, Assignment Form. As promptly as
practicable but in any event within 10 Business Days of receipt of such Assignment Form, the
Company shall, without charge, issue, register and deliver to the new holder (and the Holder, where
applicable) new Warrant(s) of like kind and tenor representing in the aggregate the right to
subscribe for the same number of Warrant Preferred Shares that could be subscribed for pursuant to
the Warrants being transferred.



     (b) At the request of the Company, the Permitted Transferee to whom a Warrant is transferred
in accordance with this Article III shall execute and deliver to the Company the



4









 




Assignment Form pursuant to which such Person agrees to become a party to, and to be bound by
the terms of and entitled to the benefits under this Agreement and the Subscription Agreement.



3.3 Loss, theft, destruction or mutilation of any Warrant




     Upon receipt of evidence reasonably satisfactory to the Company (an affidavit of the Holder
being satisfactory) of the ownership and the loss, theft, destruction or mutilation of any Warrant,
and in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably
satisfactory to the Company or, in the case of any such mutilation, upon surrender of such Warrant,
the Company shall, without charge, issue, register and deliver in lieu of such Warrant a new
Warrant of like kind representing the same rights represented by, and dated the date of, such lost,
stolen, destroyed or mutilated Warrant. Any such new Warrant shall constitute an original
contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated or
destroyed Warrant shall be at any time enforceable by any Person.



ARTICLE IV

EXERCISE OF WARRANT



4.1 Exercise of Warrants; Expiration.




     (a) On any Business Day on or prior to the Expiration Time, a Holder may exercise a Warrant,
in whole or in part, by delivering to the Company such Warrant accompanied by a properly completed
Exercise Form in the form set forth in Annex A to this Agreement. Any partial exercise of
a Warrant shall be for a whole number of Warrant Preferred Shares only.



     (b) On the Closing Date (as defined in Paragraph 4.2 below), the Holder thereof shall deliver
to the Company the consideration therefore (being an aggregate amount equal to the product of (x)
the Exercise Price and (y) the number of Warrant Preferred Shares being subscribed for) by wire
transfer of immediately available funds to a bank account designated by the Company or a certified
check payable to the Company on the relevant Closing Date;



     (c) A Warrant shall terminate and become void as of the earlier of (x) the Expiration Time and
(y) the date such Warrant is exercised in full.


4.2 Issuance of Warrant Preferred Shares.




     (a) Issuance of Warrant Preferred Shares. As promptly as practicable but on a closing date to
be agreed between the Company and the relevant Holder of the Warrant (the “Closing Date”) which
shall in any event be within 10 Business Days following the first date on which each of the
following items has been delivered to the Company (the “Delivery Date”): (i) an Exercise Form in
accordance with Section 4.1, and (ii) the related Warrant, the Company shall on the Closing
Date, without charge, upon compliance with the applicable provisions of this Agreement, against the
receipt for value of the required payment of the aggregate Exercise Price for the relevant Warrant
Preferred Shares to be determined in accordance with Section 4.1(b), issue to such Holder
one or more stock certificates or other appropriate evidence of ownership of the aggregate number
of Warrant Preferred Shares to which the Holder of such Warrant is entitled,



5









 




in such denominations, and registered or otherwise placed in such name as may be directed in
writing by such Holder.




     (b) Partial Exercise. If a Holder shall exercise a Warrant for less than all of the Warrant
Preferred Shares that could be subscribed for thereunder, the Company shall issue, register and
deliver to the Holder, as promptly as practicable but in any event within 10 Business Days
following the Delivery Date, a new Warrant evidencing the right to subscribe for the remaining
Warrant Preferred Shares represented by such Warrants. Each partial exercise shall be for a
minimum subscription of 15,000,000 Warrant Preferred Shares, or, if less than 15,000,000 Warrant
Preferred Shares are issuable under the Warrants then held by the Holder, for all of such number of
Warrant Preferred Shares issuable under the Warrants then held by the Holder. Each Warrant not
exercised on or prior to the Expiration Time pursuant to Section 4.1 shall be cancelled.



     (c) Fractional Shares. The Company shall not be required to issue fractional Warrant
Preferred Shares. If any fraction of a Warrant Preferred Share would be issuable on the exercise
of any Warrant, such fractional number shall be rounded down to the nearest whole number and such
fractional entitlement shall be deemed to have been waived by the Holder.



ARTICLE V

ADJUSTMENT AND RIGHTS OF WARRANT PREFERRED SHARES



5.1 No Adjustment.




     No adjustment shall be made to the Exercise Price nor the number of Warrant Preferred Shares
issuable upon exercise of each Warrant.


5.2 Rights attaching to the Warrant Preferred Shares.




     The Company agrees and acknowledges that each Warrant Preferred Share, upon issue, shall rank
pari passu in all respects with, and shall carry the same rights as, the Convertible Preferred
Shares; and upon signing the Assignment Form each holder of any Warrant Preferred Share shall have
the same rights as a holder of any Convertible Preferred Share under the Subscription Agreement as
if it was a party to that Subscription Agreement. For the avoidance of doubt, each Warrant
Preferred Share, upon issue, shall bear the then applicable Conversion Rate (as defined in, and
determined in accordance with, the provisions of Schedule A to the Subscription Agreement) attached, or as would have been attached, to the Convertible Preferred Shares issued initially under the
Subscription Agreement, regardless of whether any (and on the assumption that not all) of such
Convertible Preferred Shares have by then been converted into Common Shares.



6









 





ARTICLE VI

COVENANTS OF THE COMPANY



6.1 Pre-emptive Rights.




     No Warrant shall entitle the holder thereof to any pre-emptive rights or any other rights as a
shareholder of the Company.


6.2 Fees, charges and stamp duties.




     The Company will pay (if applicable) all Cayman Islands and Hong Kong stamp duties,
registration fees or similar charges in respect of the execution of this Agreement, the creation
and issue of the Warrants, the exercise of the Warrants and the issue of Warrant Preferred Shares
upon exercise of the Warrants. For the avoidance of doubt, nothing herein requires the Company to
pay or be responsible for paying any income tax or capital gains tax (if applicable) that may arise
for the account of the Holder.



ARTICLE VII

MISCELLANEOUS



7.1 Notices.




     All notices and other communications provided for or permitted hereunder shall be made by
hand-delivery, telecopier or overnight air courier guaranteeing next day delivery:



          (i) if to the Company, to:



Semiconductor Manufacturing International Corporation




			

	Address:

	 	18, Zhangjiang Road
	 

	 	Pudong New Area, Shanghai
	 

	 	People’s Republic of China
	Telephone:

	 	(86-21) 3861 0000
	Facsimile:

	 	(86-21) 5080 4000
	Attention:

	 	Barry Quan/Chief Administration Officer
	 
	 	 
	 

	 	with a copy to:
	 
	 	 
	Semiconductor Manufacturing International Corporation
	Address:

	 	Suite 3003, 30th Floor
	 

	 	No. 9 Queen’s Road Central
	 

	 	Hong Kong
	Telephone:

	 	(852) 2537-8588
	Facsimile:

	 	(852) 2537-8206
	Attention:

	 	Anne Chen/Blondie Poon






7









 






          (ii)
if to the Holder, to




	 	 	 

	Country Hill Limited
	Address:

	 	Room 2501, New Poly Plaza
	 

	 	No. 1 Chaoyangmen Beidajie
	 

	 	Dongcheng District
	 

	 	Beijing 100010
	 

	 	People’s Republic of China
	Telephone:

	 	Bai Xiaoqing at (86-10) 8409-6969
	 

	 	Li Tao at (86-10) 8409-6741
	 

	 	Li Yang at (86-10) 8409-6743
	Facsimile:

	 	(86-10) 6408-6710
	Attention:

	 	Bai Xiaoqing/Li Tao/Li Yang






     Any notices, consents, waivers or other communications required or permitted to be given under
the terms of this Agreement must be in writing and will be deemed to have been delivered: (i) upon
receipt, when delivered personally; (ii) upon receipt, when sent by facsimile (provided
confirmation of transmission is mechanically or electronically generated and kept on file by the
sending party); or (iii) one Business Day after deposit with an overnight courier service, in each
case properly addressed to the party to receive the same. The parties may change the addresses to
which notices are to be given by giving five days’ prior notice of such change in accordance
herewith.


7.2 No Voting Rights; Limitation of Liability.




     No Warrant shall entitle the holder thereof to any voting rights or any other rights as a
stockholder of the Company. No provision hereof, in the absence of affirmative action by the
Holder to subscribe for the Warrant Preferred Shares, and no enumeration herein of the rights or
privileges of the Holder shall give rise to any liability of such Holder for the Exercise Price of
Warrant Preferred Shares acquirable by exercise hereof or as an equity holder of the Company.


7.3 Amendments and Waivers.




     (a) Written Document. Any provision of this Agreement may be amended or waived, but only
pursuant to a written agreement signed by the Company and all Holders.



     (b) No Waiver. No failure on the part of any party to exercise and no delay in exercising,
and no course of dealing with respect to, any right, power or privilege under this Agreement or the
Warrants shall operate as a waiver thereof, nor shall any single or partial exercise of any right,
power or privilege under this Agreement or the Warrant preclude any other or further exercise
thereof or the exercise of any other right, power or privilege.



8









 




7.4 Counterparts.




     This Agreement may be executed in any number of counterparts and by the parties hereto in
separate counterparts, each of which when so executed shall be deemed to be an original and all of
which taken together shall constitute one and the same agreement.


7.5 Governing Law; Jurisdiction and Venue.




     All questions concerning the construction, validity, enforcement and interpretation of this
Agreement shall be governed by and construed in accordance with the laws of Hong Kong. Any
dispute, controversy or claim arising out of or relating to this Agreement, or the interpretation,
breach, termination or validity hereof, shall be submitted to arbitration upon the request of any
party with notice to the other party. The arbitration shall be conducted in Hong Kong under the
auspices of the Hong Kong International Arbitration Centre (the “HKIAC”) in accordance with the
UNCITRAL Arbitration Rules (“UNCITRAL Rules”) in effect, which rules are deemed to be incorporated
by reference into this Section 7.5. There shall be three (3) arbitrators. The complainant
and the respondent to such dispute shall each select one arbitrator within thirty (30) days after
giving or receiving the demand for arbitration. The Chairman of the HKIAC shall select the third
arbitrator, who shall be qualified to practice law in Hong Kong. If either party to the
arbitration does not appoint an arbitrator who has consented to participate within thirty (30) days
after selection of the first arbitrator, the relevant appointment shall be made by the Chairman of
the HKIAC. The arbitration proceedings shall be conducted in English. Neither party shall be
required to give general discovery of documents, but may be required to produce specific,
identified documents that are relevant to the dispute. Each party irrevocably waives, to the
fullest extent it may effectively do so, any objection which it may now or hereafter have to the
laying of venue of any such arbitration in Hong Kong and the HKIAC, and hereby submits to the
exclusive jurisdiction of HKIAC in any such arbitration. The award of the arbitration tribunal
shall be conclusive and binding upon the disputing parties, and any party to the dispute may apply
to a court of competent jurisdiction for enforcement of such award. Any party to the dispute shall
be entitled to seek preliminary injunctive relief in aid of arbitration, if possible, from any
court of competent jurisdiction pending the constitution of the arbitral tribunal.


7.6 Legality.




     If at any time any provision of this Agreement is or becomes illegal, invalid or unenforceable
in any respect, the legality, validity and enforceability of the remaining provisions of this
Agreement shall not be affected or impaired thereby.


7.7 Benefits of this Agreement.




     Nothing in this Agreement shall be construed to give to any Person other than the Company and
each Holder of a Warrant or a Warrant Preferred Share any legal or equitable right, remedy or claim
hereunder.



9









 




7.8 Headings.




     The headings in this Agreement are for convenience of reference only and shall not limit or
otherwise affect the meaning hereof.


7.9 Operative Date.




     This Agreement shall become operative on the date hereof.



[Remainder of Page Intentionally Left Blank]




10









 





     IN WITNESS WHEREOF, each party hereto has caused this Warrant Agreement to be duly executed
and delivered by its authorized signatory, all as of the date and year first above written.



	 	 	 	 	 
	 	SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION

 	 
	 	By:  	 	 
	 	 	Name:  	Jiang Shang Zhou 	 
	 	 	Title:  	Chairman of the Board 	 
	 
	 	COUNTRY HILL LIMITED

 	 
	 	By:  	 	 
	 	 	Name:  	Gao Xiqing 	 
	 	 	Title:  	Executive Director and President 	 
	 



[Signature Page to Warrant Agreement]






 









 








Exhibit A to the Warrant Agreement





     THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES OR BLUE SKY
LAWS. THESE SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN
EXEMPTION THEREFROM UNDER SAID ACT OR APPLICABLE STATE SECURITIES OR BLUE SKY LAWS.



     ADDITIONALLY, THE TRANSFER OF THESE SECURITIES IS SUBJECT TO THE CONDITIONS SPECIFIED IN THE
SHARE SUBSCRIPTION AGREEMENT, DATED AS OF 18 APRIL 2011, AND THE WARRANT AGREEMENT, DATED AS OF
[_____________ __, 20__], BETWEEN THE ISSUER HEREOF AND COUNTRY HILL LIMITED, ANOTHER SIGNATORY
THERETO. UPON THE FULFILLMENT OF CERTAIN CONDITIONS, THE ISSUER HEREOF HAS AGREED TO DELIVER TO
THE HOLDER HEREOF A NEW CERTIFICATE, NOT BEARING THIS LEGEND, FOR THE SECURITIES REPRESENTED HEREBY
REGISTERED IN THE NAME OF THE HOLDER HEREOF. COPIES OF SUCH AGREEMENTS MAY BE OBTAINED AT NO COST
BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE ISSUER
HEREOF.



Semiconductor Manufacturing International Corporation




			
	 	 	 
	No. W — 1 — [ ]
	 	[_________, __, 20__]





Convertible Preferred Share Subscription Warrant




     THIS CERTIFIES that, for value received, Country Hill Limited, an exempted company
incorporated in the Cayman Islands with limited liability (the “Holder”), or its assigns, is
entitled to subscribe from Semiconductor Manufacturing International Corporation, an exempted
company incorporated under the laws of the Cayman Islands (the “Company” or “Issuer”), 72,117,810
convertible preferred shares, US$.0004 par value (the “Convertible Preferred Shares”), of the
Company (the “Warrant Preferred Shares”), at the price (the “Exercise Price”) of HK$5.3900 per
share, at any time or from time to time during the period commencing on the date hereof and ending
at the Expiration Time (as defined in the Warrant Agreement).



     The Holder may exercise all or any part of such rights at any time or from time to time prior
to the Expiration Time.



     This Warrant has been issued pursuant to the Warrant Agreement dated as of [_________ __,
20__] (as amended, restated, supplemented or otherwise modified from time to time, the “Warrant
Agreement”) between the Company and the Initial Holder named therein, and is subject to the terms
and conditions, and the Holder is entitled to the benefits, thereof. A copy of the Warrant
Agreement is on file and may be inspected at the principal executive office of the



A-1 









 




Company. The Holder of this certificate, by acceptance of this certificate, agrees to be
bound by the provisions of the Warrant Agreement. Capitalised terms used but not defined herein
shall have the respective meanings given to such terms in the Warrant Agreement.




     SECTION 1. Exercise of Warrant. On any day on or prior to the Expiration Time, the Holder
may exercise this Warrant, in whole or in part, in the manner set forth in Article IV of
the Warrant Agreement.



     SECTION 2. Transfer. Save as pursuant to Article III of the Warrant Agreement, this Warrants
is not transferable without the prior written approval of the issuer hereof which shall have sole
and absolute discretion thereon.



     SECTION 3. Lost, Stolen, Mutilated or Destroyed Warrant. If this Warrant is lost, stolen,
mutilated or destroyed, the Company will issue a new Warrant of like denomination and tenor upon
compliance with the provisions set forth in the Warrant Agreement.



     SECTION 4. Successors. All of the provisions of this Warrant by or for the benefit of the
Company or the Holder shall bind and inure to the benefit of their respective successors and
permitted assigns.



     SECTION 5. Headings. Section headings in this Warrant have been inserted for convenience of
reference only and shall not affect the construction of, or be taken into consideration in
interpreting, this Warrant.



     SECTION 6. Governing Law. All questions concerning the construction, validity, enforcement
and interpretation of this Agreement shall be governed by and construed in accordance with the laws
of Hong Kong. Any dispute, controversy or claim arising out of or relating to this Agreement, or
the interpretation, breach, termination or validity hereof, shall be submitted to arbitration upon
the request of any party with notice to the other party. The arbitration shall be conducted in
Hong Kong under the auspices of the HKIAC in accordance with the UNCITRAL Rules in effect, which
rules are deemed to be incorporated by reference into this section. There shall be three (3)
arbitrators. The complainant and the respondent to such dispute shall each select one arbitrator
within thirty (30) days after giving or receiving the demand for arbitration. The Chairman of the
HKIAC shall select the third arbitrator, who shall be qualified to practice law in Hong Kong. If
either party to the arbitration does not appoint an arbitrator who has consented to participate
within thirty (30) days after selection of the first arbitrator, the relevant appointment shall be
made by the Chairman of the HKIAC. The arbitration proceedings shall be conducted in English.
Neither party shall be required to give general discovery of documents, but may be required to
produce specific, identified documents that are relevant to the dispute. Each party irrevocably
waives, to the fullest extent it may effectively do so, any objection which it may now or hereafter
have to the laying of venue of any such arbitration in Hong Kong and the HKIAC, and hereby submits
to the exclusive jurisdiction of HKIAC in any such arbitration. The award of the arbitration
tribunal shall be conclusive and binding upon the disputing parties, and any party to the dispute
may apply to a court of competent jurisdiction for enforcement of such award. Any party to the
dispute shall be entitled to seek preliminary



A-2 









 




injunctive relief in aid of arbitration, if possible, from any court of competent jurisdiction
pending the constitution of the arbitral tribunal.




     IN WITNESS WHEREOF, the undersigned has caused this Warrant to be executed by its duly
authorized officers and this Warrant to be dated as of the date first set forth above.



	 	 	 	 	 
	 	SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION

 	 
	 	By:  	 	 
	 	 	Name:  	Jiang Shang Zhou 	 
	 	 	Title:  	Chairman of the Board 	 
	 




A-3 









 








Annex A to the Warrant




EXERCISE FORM



[To be signed upon exercise of a Warrant]



TO SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION:





     The undersigned, being the Holder of the attached Warrants, hereby elects to exercise the
subscription right represented by such/such portion of the Warrants for, and to subscribe for
thereunder, _________ Convertible Preferred Shares of Semiconductor Manufacturing International
Corporation, an exempted company incorporated under the laws of the Cayman Islands (the “Company”),
and requests that the certificates or other evidence of ownership for such shares and a new Warrant
certificate for the remaining unexercised Warrants be issued in the name of, and be delivered to,
_______________________, whose address is ________________________ ___________________________.



	 	 	 	 	 	 	 

	Dated:
	 	 	 	 	 	 
	 

	 	 
	 	 	 	 
	 

	 	 	 	 	 	Name:
	 

	 	 	 	 	 	Title:






 









 





Annex B to the Warrant




ASSIGNMENT FORM



[To be signed only upon transfer of a Warrant]



     For value received, the undersigned hereby sells, assigns and transfers unto
______________________, a Permitted Transferee (as defined in the Warrant Agreement) of the holder
of the Warrants represented by the above certificate, all/part of the rights represented by the
above Warrants to subscribe for _________ Convertible Preferred Shares of Semiconductor
Manufacturing International Corporation, an exempted company incorporated under the laws of the
Cayman Islands (the “Company”), to which such Warrants relate.



	 	 	 	 	 	 	 	 	 

	Dated:
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	By:	 	 
	 

	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Holder of the Warrants
	 	 	 	 	 	 	Name:
	 	 	 	 	 	 	Title:






     By executing and delivering this Assignment Form to the Company, the undersigned hereby agrees
to become a party to, to be bound by, and to comply with the provisions of the Warrant Agreement
dated as of [________ __, 20__] (as amended, restated, supplemented or otherwise modified from time
to time, the “Warrant Agreement”), between the Company and the Initial Holder, in the same manner
as if the undersigned were an original signatory to the Warrant Agreement and the Subscription
Agreement (as defined in the Warrant Agreement), and to become a
“Holder” (as defined in the Warrant
Agreement).




	 	 	 	 	 	 	 

	Dated:
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	Signature of transferee
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	Print Name of transferee
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	Address
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	Facsimile
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	Telephone







D-